TW201241224A - Hafnium-containing or zirconium-containing precursors for vapor deposition - Google Patents

Hafnium-containing or zirconium-containing precursors for vapor deposition Download PDF

Info

Publication number
TW201241224A
TW201241224A TW100112135A TW100112135A TW201241224A TW 201241224 A TW201241224 A TW 201241224A TW 100112135 A TW100112135 A TW 100112135A TW 100112135 A TW100112135 A TW 100112135A TW 201241224 A TW201241224 A TW 201241224A
Authority
TW
Taiwan
Prior art keywords
ipr
oipr
02cme
nme2
molecule
Prior art date
Application number
TW100112135A
Other languages
Chinese (zh)
Other versions
TWI518199B (en
Inventor
Venkateswara R Pallem
Christian Dussarrat
Original Assignee
Air Liquide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide filed Critical Air Liquide
Priority to TW100112135A priority Critical patent/TWI518199B/en
Publication of TW201241224A publication Critical patent/TW201241224A/en
Application granted granted Critical
Publication of TWI518199B publication Critical patent/TWI518199B/en

Links

Abstract

Disclosed are hafnium-containing and zirconium-containing precursors and methods of synthesizing the same. The compounds may be used to deposit hafnium, zirconium, hafnium oxide, and zirconium oxide containing layers using vapor deposition methods such as chemical vapor deposition or atomic layer deposition.

Description

201241224 、發明說明: 【發明所屬之技術領域】 揭示含鈴及含锆前驅物、 法’及使用含給及含錯前驅物 給及含錯層之方法。 合成含給及含錯·前驅物之方 以使用氣相沉積製程沉積含 【先前技術】 半導體工業面臨之嚴重挑戰中之一者為開發用於 DRAM及電谷器之新的閘極介電材料。數十年中,二氧化 石夕(SA)為可靠介電質,但隨著電晶體繼續收縮且技術自 「全si」電晶體移至「金屬閘極/高k」電晶體,基於si〇2 之閘極介電質之可靠性達到其物理限制。隨著用於當前技 術之大小收縮,對新的高介電常數材料及製程之需要曰益 增加且變得愈來愈關鍵。 美國專利申請公開案第2005/277223號揭示了使用具 有式M(Ll)x(L2)y之含金屬前驅物形成金屬氧化物之ALD 方法’其中Μ為金屬,L1及L2可為鹵化物、二酮、醇鹽、 胺基、烷氧基胺、脒鹽或多牙配位基。然而,例示性前驅 物僅為 Hf(〇tBu)2(NEtMe)2 、 Hf(OtBu)2(NEt2)2 、 Hf(NEt2)2(DMAMP)2、Hf(NEtMe)2(DMAMP)2、Ti(OtBu)3C卜 Ti(OtBU)3Me、Ti(OtBu)2(NEt2)2、Ti(NEt2)2(DMAMP)2、 Ti(OtBu)2(DMAMP)2,及 TiCl2(DMAMP)2。 美國專利第7,491,654號揭示了使用參(N-乙基-N-曱胺 基)(第三丁氧基)锆前驅物形成Zr02薄膜之ALD方法。 正為新一代積體電路裝置搜尋併有含Hf及含Zr材料 201241224 之其他來源及方法。需要新穎前驅物。 【發明内容】 揭示具有以下式之分子:·201241224, the invention description: [Technical Field] The invention discloses a method for containing a bell and a zirconium-containing precursor, a method, and a method for using a mixed precursor and a miscible precursor. Synthesis of conjugated and precursor-containing precursors for deposition using vapor deposition processes [Prior Art] One of the serious challenges facing the semiconductor industry is the development of new gate dielectric materials for DRAMs and valleys. . For decades, dioxide (SA) is a reliable dielectric, but as the transistor continues to shrink and the technology moves from a "all-si" transistor to a "metal gate/high-k" transistor, based on si〇 The reliability of the gate dielectric of 2 reaches its physical limit. As the size shrinkage for current technology, the need for new high dielectric constant materials and processes has increased and become more critical. U.S. Patent Application Publication No. 2005/277223 discloses an ALD method for forming a metal oxide using a metal-containing precursor having the formula M(Ll)x(L2)y, wherein ruthenium is a metal, and L1 and L2 may be a halide. Diketone, alkoxide, amine group, alkoxyamine, phosphonium salt or polydentate ligand. However, the exemplary precursors are only Hf(〇tBu)2(NEtMe)2, Hf(OtBu)2(NEt2)2, Hf(NEt2)2(DMAMP)2, Hf(NEtMe)2(DMAMP)2, Ti (OtBu) 3C, Ti(OtBU)3Me, Ti(OtBu)2(NEt2)2, Ti(NEt2)2(DMAMP)2, Ti(OtBu)2(DMAMP)2, and TiCl2(DMAMP)2. U.S. Patent No. 7,491,654 discloses an ALD process for forming a ZrO 2 film using a ginseng (N-ethyl-N-nonylamino) (t-butoxy)zirconium precursor. Other sources and methods for Hf and Zr-containing materials 201241224 are being searched for for a new generation of integrated circuit devices. A new precursor is needed. SUMMARY OF THE INVENTION A molecule having the following formula is disclosed:

Md-N-CiD-N-RdJORddNRsDAOzCRdz 式 I 或Md-N-CiD-N-RdJORddNRsDAOzCRdz Formula I or

M(R1-N-(C(R3)2)m-N-R2)v(〇R4)x(NR5R6)y(〇2CR7)2 式 II 其中: Μ 為 Hf 或 Zr ; _ Ri ' R2、R5、R6及R7獨立地選自由Η及C1-C6炫基 組成之群; R3 = Η、C1-C6 烷基,或 NMe2 ; • R4為C1-C6烷基; • m = 2 至 4 ; • u = 0 至 2 ; v = 〇 至 1 ; x = 1 至 3 ; • y = 0 至 2 ; z = 〇 至 1 ; 在式 I 中,u+x+y+z == 4 ; •在式 II 中,2v+x+y+z = 4 ;且 u、v 或 z k 1 〇 該等所揭示之分子巧'進一步包括以下態樣中之一或多 者: .— •該分子具有式I,其中u=l,x=3,y=0,且z=〇 ; 201241224 •該分子選自由以下各者組成之群 : M(iPr-N-C(Me)-N-iPr)!(OiPr)3 ' M(iPr-N-C(Me)-N-iPr)!(OMe)3 ' M(iPr-N-C(Me)-N-iPr)!(OEt)3 ' M(iPr-N-C(Me)-N-iPr)!(OnPr)3 ' M(iPr-N-C(Me)-N-iPr)!(OsBu)3 > M(iPr-N-C(Me)-N-iPr)!(OiBu)3 ' M(iPr-N-C(Me)-N-iPr)!(OtBu)3 ' M(Et-N-C(Me)-N-Et),(OEt)3 ' M(Et-N-C(Me)-N-Et)!(OMe)3、M(Et-N-C(Me)-N-Et)!(OnPr)3、 M(Et-N-C(Me)-N-Et)!(OsBu)3 ' M(Et-N-C(Me)-N-Et)!(OiBu)3 > MCEt-N-C^MehN-EthCOtBuV 及 M(iPr-N-C(NMe2)-N-iPr)(OiPr)3 •該分子具有式II’其中v=l,x=2,y=0,且z = 0 ; •該分子選自由以下各者組成之群 : M(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)2-N-iPr)1(OMe)2、 M(iPr-N-(CH2)2-N-iPr) 1 (0Et)2、 M(iPr-N-(CH2)2-N-iPr)1(OsBu)2 M(iPr-N-(CH2)2-N-iPr),(OtBu)2 M(Et-N-(CH2)2-N-Et)i(OMe)2 、 M(Et-N-(CH2)2-N-Et),(OnPr)2 ' M(Et-N-(CH2)2-N-Et)1(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)1(OsBu)2 M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' • M(iPr-N-(CH2)2-N-iPr)1(OiBu)2 ' ' M(Et-N-(CH2)2-N-Et),(OiPr)2 ' M(Et-N-(CH2)2-N-Et)i(OEt)2 、 M(Et-N-(CH2)2-N-Et)1(OsBu)2 ' M(Et-N-(CH2)2-N-Et),(OtBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OMe)2 ' M(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' • M(iPr-N-(CH2)3-N-iPr),(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OtBu)2 ' M(Et-N-(CH2)3-N-Et),(OiPr)2 ' M(Et-N-(CH2)3-N-Et)i(OMe)2 、 M(Et-N-(CH2)3-N-Et)i(OEt)2 、 M(Et-N-(CH2)3-N-Et)1(OnPr)2 ' M(Et-N-(CH2)3-N-Et)l(OsBu)2 ' MCEt-N-CCHA-N-EOKOiBuh,及 IVKEt-N-CCHA-N-EtMOtBuh ; 201241224 •該分子具有式I,其中u = 2,x=2,y=0,且z=0 ; •該分子選自由以下各者組成之群 M(iPr-N-C(H)-N-iPr)2(OiPr)2 M(iPr-N-C(H)-N-iPr)2(OEt)2 M(iPr-N-C(H)-N-iPr)2(OsBu)2 M(iPr-N-C(H)-N-iPr)2(OtBu)2 M(Et-N-C(H)-N-Et)2(OMe)2 M(Et-N-C(H)-N-Et)2(OnPr)2 、M(iPr-N-C(H)-N-iPr)2(〇Me)2 、M(iPr-N-C(H)-N-iPr)2(OnPr)2 、M(iPr-N-C(H)-N-iPr)2(OiBu)2 、M(Et-N-C(H)-N-Et)2(〇iPr)2 、M(Et-N-C(H)-N-Et)2(OEt)2 、M(Et-N-C(H)-N-Et)2(OsBu)2 M(Et-N-C(H)-N-Et)2(OiBu)2 、 M(Et-N-C(H)-N-Et)2(OtBu)2 、 M(iPr-N-C(Me)-N-iPr)2(OiPr)2、M(iPr-N-C(Me)-N-iPr)2(OMe)2、 M(iPr-N-C(Me)-N-iPr)2(OEt)2、M(iPr-N-C(Me)-N-iPr)2(OnPr)2、 M(iPr-N-C(Me)-N-iPr)2(OsBu)2、M(iPr-N-C(Me)-N-iPr)2(OiBu)2、 M(iPr-N-C(Me)-N-iPr)2(OtBu)2、M(Et-N-C(Me)-N-Et)2(OiPr)2、 M(Et-N-C(Me)-N-Et)2(OMe)2 、 M(Et-N-C(Me)-N-Et)2(〇Et)2 、 M(Et-N-C(Me)-N-Et)2(OnPr)2、M(Et-N-C(Me)-N-Et)2(OsBu)2、 M(Et-N-C(Me)-N-Et)2(OiBu)2,及 M(Et-N-C(Me)-N-Et)2(OtBu)2 ; •該分子具有式I,其中u=l,x = 2,y=l,且z=0 ; •該分子選自由以下各者組成之群 : M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NMe2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEt2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe) 、 6 201241224 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2) M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2) , M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe) M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr) M(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2) M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu) M(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2) M(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr) M(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2) M(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2) M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr) M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2) M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) M(iPr-!N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr); •該分子具有式I,其中u=l,x = 2,y=0,且 •該分子選自由以下各者組成 M(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) M(Et-N-C(Me)-N-Et)(0iPr)2(02CMe); •該分子具有式II,其中v=l,x=l,y=0,且 •該分子選自由以下各者組成 M(iPr-N-(CH2)2-N-iPr)(0iPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) 201241224 M(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0Me)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0Et)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0sBu)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0iBu)(02CMe) , 及 M(Et-N-(CH2)2-N-Et)(0tBu)(02CMe); •該分子具有式I或式Π,其中u、v、y=〇,χ = 2,且 z=2 ; •該分子為 M(0iPr)2(02CMe)2 ; •該分子具有式I或式Π,其中u、v、y=〇,χ=3,且 ζ=1 ;及 •該分子為 M(0iPr)3(02CMe)。 亦揭示在基板上形成含Hf或含Zr層之方法。提供& 應腔室,該反應腔室内安置有至少一基板。將上文所揭示 之該等分子中之至少一者的蒸汽引入至該反應腔室中。使 該蒸汽與該基板接觸以使用氣相沉積製程在該基板之至少 一表面上形成含Hf或含Zr層。該等所揭示之方法可進— 步包括以下態樣中之一或多者: 記號及命名法 特定縮寫、符號及術語係貫穿以下描述及申請專利範 8 201241224 代錯鈦酸鉛; 以下化學結構 圍而使用且包括:縮寫「PZT」指 縮寫「Ri-NCd)!^-!^」指代M(R1-N-(C(R3)2)mN-R2)v(〇R4)x(NR5R6)y(〇2CR7)2 Formula II wherein: Μ is Hf or Zr; _ Ri ' R2, R5, R6 And R7 are independently selected from the group consisting of hydrazine and a C1-C6 ray group; R3 = Η, C1-C6 alkyl, or NMe2; • R4 is a C1-C6 alkyl group; • m = 2 to 4; • u = 0 To 2; v = 〇 to 1; x = 1 to 3; • y = 0 to 2; z = 〇 to 1; in Equation I, u+x+y+z == 4; • In Equation II, 2v+x+y+z = 4; and u, v or zk 1 〇 these revealed molecules are further comprising one or more of the following: .- • The molecule has the formula I, where u= l, x=3, y=0, and z=〇; 201241224 • The molecule is selected from the group consisting of: M(iPr-NC(Me)-N-iPr)!(OiPr)3 ' M(iPr -NC(Me)-N-iPr)!(OMe)3 ' M(iPr-NC(Me)-N-iPr)!(OEt)3 ' M(iPr-NC(Me)-N-iPr)!( OnPr)3 ' M(iPr-NC(Me)-N-iPr)!(OsBu)3 > M(iPr-NC(Me)-N-iPr)!(OiBu)3 ' M(iPr-NC(Me )-N-iPr)!(OtBu)3 ' M(Et-NC(Me)-N-Et),(OEt)3 ' M(Et-NC(Me)-N-Et)!(OMe)3, M(Et-NC(Me)-N-Et)!(OnPr)3, M(Et-NC(Me)-N-Et)!(OsBu)3 ' M(Et-NC(Me)-N-Et )!(OiBu)3 > MCEt-NC^MehN-EthCOtBuV And M(iPr-NC(NMe2)-N-iPr)(OiPr)3 • The molecule has the formula II' wherein v=l, x=2, y=0, and z = 0; • the molecule is selected from the following Group consisting of: M(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)2-N-iPr)1(OMe)2, M(iPr -N-(CH2)2-N-iPr) 1 (0Et)2, M(iPr-N-(CH2)2-N-iPr)1(OsBu)2 M(iPr-N-(CH2)2-N -iPr), (OtBu) 2 M(Et-N-(CH2)2-N-Et)i(OMe)2 , M(Et-N-(CH2)2-N-Et), (OnPr)2 ' M(Et-N-(CH2)2-N-Et)1(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2 )3-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)1(OsBu)2 M(iPr-N-(CH2)2-N-iPr)1( OnPr)2 ' • M(iPr-N-(CH2)2-N-iPr)1(OiBu)2 ' ' M(Et-N-(CH2)2-N-Et), (OiPr)2 ' M( Et-N-(CH2)2-N-Et)i(OEt)2, M(Et-N-(CH2)2-N-Et)1(OsBu)2 ' M(Et-N-(CH2)2 -N-Et),(OtBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OMe)2 ' M(iPr-N-(CH2)3-N-iPr)1(OnPr ) 2 ' • M(iPr-N-(CH2)3-N-iPr), (OiBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OtBu)2 ' M(Et- N-(CH2)3-N-Et),(OiPr)2 ' M(Et-N-(CH2)3-N-Et)i(OMe)2 , M(Et-N-(CH2)3-N -Et)i(OEt)2, M(Et-N-(CH2)3-N-Et)1(OnPr)2 ' M(Et-N-(CH2)3-N-Et)l(OsBu)2 ' MCEt-N-CCHA-N-EOKOiBuh, and IVKEt-N-CC HA-N-EtMOtBuh ; 201241224 • The molecule has the formula I, where u = 2, x = 2, y = 0, and z = 0; • The molecule is selected from the group consisting of the following M (iPr-NC (H )-N-iPr)2(OiPr)2 M(iPr-NC(H)-N-iPr)2(OEt)2 M(iPr-NC(H)-N-iPr)2(OsBu)2 M(iPr -NC(H)-N-iPr)2(OtBu)2 M(Et-NC(H)-N-Et)2(OMe)2 M(Et-NC(H)-N-Et)2(OnPr) 2, M(iPr-NC(H)-N-iPr)2(〇Me)2, M(iPr-NC(H)-N-iPr)2(OnPr)2, M(iPr-NC(H)- N-iPr)2(OiBu)2, M(Et-NC(H)-N-Et)2(〇iPr)2, M(Et-NC(H)-N-Et)2(OEt)2, M (Et-NC(H)-N-Et)2(OsBu)2 M(Et-NC(H)-N-Et)2(OiBu)2, M(Et-NC(H)-N-Et)2 (OtBu)2, M(iPr-NC(Me)-N-iPr)2(OiPr)2, M(iPr-NC(Me)-N-iPr)2(OMe)2, M(iPr-NC(Me )-N-iPr)2(OEt)2, M(iPr-NC(Me)-N-iPr)2(OnPr)2, M(iPr-NC(Me)-N-iPr)2(OsBu)2 M(iPr-NC(Me)-N-iPr)2(OiBu)2, M(iPr-NC(Me)-N-iPr)2(OtBu)2, M(Et-NC(Me)-N-Et 2(OiPr)2, M(Et-NC(Me)-N-Et)2(OMe)2, M(Et-NC(Me)-N-Et)2(〇Et)2, M(Et- NC(Me)-N-Et)2(OnPr)2, M(Et-NC(Me)-N-Et)2(OsBu)2, M(Et-NC(Me)-N-Et)2(OiBu 2, and M (Et-NC(Me)-N-Et) 2(OtBu) 2 ; • The molecule has the formula I, where u= l, x = 2, y = l, and z = 0; • The molecule is selected from the group consisting of: M(iPr-NC(Me)-N-iPr)(OiPr)2(NMe2), M( iPr-NC(Me)-N-iPr)(OiPr)2(NEt2), M(iPr-NC(Me)-N-iPr)(OiPr)2(NEtMe), M(Et-NC(Me)-N -Et)(OiPr)2(NMe2), M(Et-NC(Me)-N-Et)(OiPr)2(NEt2), M(Et-NC(Me)-N-Et)(OiPr)2( NEtMe) , 6 201241224 M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMe2) M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NEt2) , M(iPr- NC(NMe2)-N-iPr)(OiPr)2(NEtMe) M(iPr-NC(Me)-N-iPr)(OiPr)2(NMeiPr) M(iPr-NC(Me)-N-iPr)( OiPr)2(NiPr2) M(iPr-NC(Me)-N-iPr)(OiPr)2(NMetBu) M(iPr-NC(Me)-N-iPr)(OiPr)2(NneoPentyl2) M(Et- NC(Me)-N-Et)(OiPr)2(NMeiPr) M(Et-NC(Me)-N-Et)(OiPr)2(NiPr2) M(Et-NC(Me)-N-Et)( OiPr)2(NneoPentyl2) M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMeiPr) M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NiPr2) M(iPr- NC(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) M(iPr-!NC(NMe2)-N-iPr)(OiPr)2(NMeiPr); • The molecule has the formula I, where u=l, x = 2, y = 0, and • The molecule is selected from the group consisting of M(iPr-NC(Me)-N-iPr)(0iPr)2(02CMe) M(Et-NC(Me)-N-Et )(0iPr)2(02CM e); • The molecule has the formula II, where v=l, x=l, y=0, and • the molecule is selected from the group consisting of M(iPr-N-(CH2)2-N-iPr) (0iPr (02CMe) M(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) M(iPr- N-(CH2)2-N-iPr)(0nPr)(02CMe) 201241224 M(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe) , M(iPr-N-(CH2)2 -N-iPr)(0iBu)(02CMe) , M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) , M(Et-N-(CH2)2-N-Et)( 0iPr)(02CMe), M(Et-N-(CH2)2-N-Et)(0Me)(02CMe), M(Et-N-(CH2)2-N-Et)(0Et)(02CMe), M(Et-N-(CH2)2-N-Et)(0nPr)(02CMe), M(Et-N-(CH2)2-N-Et)(0sBu)(02CMe), M(Et-N- (CH2)2-N-Et)(0iBu)(02CMe), and M(Et-N-(CH2)2-N-Et)(0tBu)(02CMe); • The molecule has the formula I or formula, wherein u, v, y = 〇, χ = 2, and z = 2; • The molecule is M(0iPr) 2(02CMe) 2 ; • The molecule has the formula I or Π, where u, v, y = 〇, χ=3, and ζ=1; and • The molecule is M(0iPr)3(02CMe). A method of forming a Hf-containing or Zr-containing layer on a substrate is also disclosed. Providing a & chamber, at least one substrate disposed within the reaction chamber. Vapor of at least one of the molecules disclosed above is introduced into the reaction chamber. The vapor is brought into contact with the substrate to form an Hf-containing or Zr-containing layer on at least one surface of the substrate using a vapor deposition process. The methods disclosed herein may include one or more of the following: Symbols and nomenclature specific abbreviations, symbols, and terms are used throughout the following description and patent application No. 8 201241224 Displacement lead titanate; Used and included: the abbreviation "PZT" means the abbreviation "Ri-NCd"! ^-!^"

縮寫「R丨-N(C(R3)2)m_N-R2J指代以下化學結構:The abbreviation "R丨-N(C(R3)2)m_N-R2J refers to the following chemical structure:

縮寫「〇2CR_7」指代以下化學結構:The abbreviation "〇2CR_7" refers to the following chemical structure:

縮寫「Cy」指代環己基;縮寫「Cp」指代環戊二烯; 術語「脂族基」指代C1-C6直鏈或分支鏈烷基;術語「烷 基j指代僅含有碳原子及氫原子之飽和官能基且包括直鏈 烧基、分支鏈烷基或環烷基。直鏈烷基之實例包括(不限 201241224 制)甲基、乙基、正丙基'正丁基等。分支鏈烷基之實例 包括(不限制)第三丁基。環烷基之實例包括(不限制) 環丙基、環丁基、環戊基、環己基等。縮寫「Me」指代甲 基;縮寫「Et」指代乙基;縮寫「pr」指代丙基;縮寫「听」 指代異丙基; '縮寫「iBu」指代異丁基;縮冑「.」指代 正丁基,縮寫「sBu」指代第二丁基;縮寫「_」指代第 二 丁基;縮寫「Nz-amd」指代 Rl_NC(R3) n_r2,其中 R;= C1-C6烷基且R丨及r2 = z,z經定義為心、以、卜、听、 iBu sBu 或 tBu,例如 NMe-amd 為 Me-NC(Me)N-Me ; 縮寫「Nz-fmd」指代 Rl_Nc(R3) N_R2,其中 & = H 且 & 及R2 = z,z經定義為Me、Et、Pr、ipr或縮寫「nz_㈣ 指代 r|-nc(R3)n-R2,其中 l = nr5r6,其中 Rs 及 R6 = ^ lPr、nBu、iBu、sBl^tBu;縮寫「聊」指代四氮咬喃 縮寫「TMA」指代三甲基紹;縮寫「則」指代原子層识 積,縮寫「CVD」指代化學氣相沉積;縮寫「咖相The abbreviation "Cy" refers to cyclohexyl; the abbreviation "Cp" refers to cyclopentadiene; the term "aliphatic" refers to a C1-C6 straight or branched alkyl group; the term "alkyl j refers to a carbon atom only And a saturated functional group of a hydrogen atom and includes a linear alkyl group, a branched alkyl group or a cycloalkyl group. Examples of the linear alkyl group include (not limited to 201241224) methyl, ethyl, n-propyl 'n-butyl, and the like. Examples of branched alkyl groups include, without limitation, a third butyl group. Examples of cycloalkyl groups include, without limitation, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, etc. The abbreviation "Me" refers to a The abbreviation "Et" refers to an ethyl group; the abbreviation "pr" refers to a propyl group; the abbreviation "hear" refers to isopropyl; the abbreviation "iBu" refers to an isobutyl group; the abbreviation "iBu" refers to an isobutyl group; Base, the abbreviation "sBu" refers to the second butyl; the abbreviation "_" refers to the second butyl; the abbreviation "Nz-amd" refers to Rl_NC(R3) n_r2, where R; = C1-C6 alkyl and R丨And r2 = z, z is defined as heart, y, b, listen, iBu sBu or tBu, for example NMe-amd is Me-NC(Me)N-Me; the abbreviation "Nz-fmd" refers to Rl_Nc(R3) N_R2 , where & = H and &及; and R2 = z,z is defined as Me, Et, Pr, ipr or the abbreviation "nz_(4) refers to r|-nc(R3)n-R2, where l = nr5r6, where Rs and R6 = ^ lPr, nBu, iBu, sBl^tBu; the abbreviation "talk" refers to the abbreviation "TMA" refers to trimethyl sulphate; the abbreviation "" refers to atomic layer characterization, the abbreviation "CVD" refers to chemical vapor deposition; "Cafes

代低壓化學氣相沉積;縮寫「P 円r LVD」指代脈衝化學氣相识 積’縮寫PE-ALD」指代雷难掷Generation of low pressure chemical vapor deposition; the abbreviation "P 円r LVD" refers to pulsed chemical vapor identification 'abbreviation PE-ALD' refers to the difficult to throw

電桌a強原子層沉積;縮寫「MIM 才曰代金屬絕緣體金屬(用於電容 指代動態隨機存取記㈣.二。構)’縮寫_ 匕隐體,縮寫「FeRAM」指代鐵電隨招 存取記憶體;縮寫「CMOS」指# $i Γ ^ 」日代互補金氧半導體;縮旁 TGA」指代熱解重量分析。 解 本文中使用來自元素週期表之 ,可藉由此專縮寫來參考元素( 元素的標準縮寫 例如,Hf指代給 。應理 ,Zr指 10 201241224 代锆,等等)。 【實施方式】 揭示新穎含铪及含鍅前驅物,合成含铪及含锆前驅物 之方法,及使用含铪及含錯前驅物之方法。 該等所揭示之混配含铪及含錯前驅物衍生自不同類別 之配位基系統,諸如脒鹽、甲脒鹽、胍鹽、醯胺,及/或螯 合醯胺配位基,加醇鹽配位基。前驅物設計可幫助改良揮 發性’減小熔點(液體或極低熔融固體),增加與水之反應 性,且增加用於較寬製程窗應用之熱穩定性。 該等所揭示之含铪及含锆前驅物具有以下式:Electric table a strong atomic layer deposition; the abbreviation "MIM is the metal insulator metal (for capacitance refers to dynamic random access memory (4). II. Structure) 'abbreviation _ 匕 hidden body, the abbreviation "FeRAM" refers to the ferroelectric Access memory; the abbreviation "CMOS" refers to # $i Γ ^ "daily complementary MOS; tailed TGA" refers to thermogravimetric analysis. Solution In this paper, we use the periodic table of elements, which can be referred to by the abbreviations (the standard abbreviations of the elements, for example, Hf refers to .., Zr refers to 10 201241224 zirconium, etc.). [Embodiment] A novel method for synthesizing cerium-containing and cerium-containing precursors, synthesizing cerium-containing and zirconium-containing precursors, and a method using cerium-containing and erroneous precursors are disclosed. The disclosed mixed ruthenium-containing and mis-containing precursors are derived from different classes of ligand systems, such as sulfonium salts, formamidine salts, sulfonium salts, decylamines, and/or chelating guanamine ligands, plus Alkoxide ligand. The precursor design helps to improve the volatility of 'reducing the melting point (liquid or very low melting solids), increasing the reactivity with water, and increasing the thermal stability for wider process window applications. The yttrium-containing and zirconium-containing precursors disclosed herein have the following formula:

M(Rl'N-c(R3) N-R2)u(〇R4)x(NR5R6)y(02CR7)z 式 I 或 M(Rl-N'(C(R3)2)m-N.R2)v(0R4)x(NRsR6)y(02CR7)z 式 Π 其中: M 為 Hf 或 Zr ; R】、R2、R5、汉6及R7獨立地選自由Η及C1-C6烷基 組成之群; Κ·3 = Η、C1-C6 烷基,或 NMe2 ; R4為C1-C6烷基; m =2 至 4 ; u = :0 至 2 ; V = 0 至 1 ; X = 1 至 3 ; y = 0 至 2 ; 11 201241224 z = 〇 至 1 ; 在式 I 中,u+x+y+z = 4 ; 在式 II 中,2v+x+y+z = 4 ;且 u、v 或 z >1。 如上文所定義’該C1-C6烷基包括具有1至6個碳原 子之任何直鏈烧基、分支鍵烧基或環炫基,包括(但不限 於)Me、tBu或環己基。 在式1中’該R^NC^RON-R2配位基具有以下化學結構:M(Rl'Nc(R3) N-R2)u(〇R4)x(NR5R6)y(02CR7)z Formula I or M(Rl-N'(C(R3)2)mN.R2)v(0R4) x(NRsR6)y(02CR7)z Formula: wherein: M is Hf or Zr; R], R2, R5, Han 6 and R7 are independently selected from the group consisting of ruthenium and C1-C6 alkyl; Κ·3 = Η , C1-C6 alkyl, or NMe2; R4 is C1-C6 alkyl; m = 2 to 4; u = :0 to 2; V = 0 to 1; X = 1 to 3; y = 0 to 2; 201241224 z = 〇 to 1; in the formula I, u+x+y+z = 4; in the formula II, 2v+x+y+z = 4; and u, v or z >1. As defined above, the C1-C6 alkyl group includes any linear alkyl group, branched bond group or cyclohexyl group having from 1 to 6 carbon atoms, including but not limited to Me, tBu or cyclohexyl. In Formula 1, the R^NC^RON-R2 ligand has the following chemical structure:

R2 在式II中’該配位基具有以下化 學結構: /4) (C(R3)2)mR2 is in Formula II 'The ligand has the following chemical structure: /4) (C(R3)2)m

Ri 因此’雖然相同元素維持於該配位基之主鏈(亦即, N C-N-)中’但該配位基自身自在該-N_c-N主鏈之間具有 個非疋域負電4之_ i配位基轉向具有定域於每一氣原子 處之-個負電荷之_2配位基。另夕卜,該式】配位基具有比 12 201241224 該式II配位基更硬質之結構。 當Ri及R3為式I中之C1-C6直鏈或分支鏈烧基時,Ri 及R3可為獨立取代基或其可連接在一起以形成自Ri延伸至 尺3之單環結構,如下文所論證。 c 1¾Ri therefore 'although the same element is maintained in the backbone of the ligand (ie, N CN-)' but the ligand itself has a non-疋 domain negative charge between the -N_c-N backbones_ The i-ligand is turned to a _2 ligand having a negative charge localized to each gas atom. In addition, the formula has a structure which is harder than the ligand of the formula II 2012122424. When Ri and R3 are C1-C6 straight or branched alkyl groups of formula I, Ri and R3 may be independent substituents or they may be joined together to form a single ring structure extending from Ri to Rule 3, as follows Argument. c 13⁄4

\ I\ I

Ri - N-C- N- R2 類似地,當R,、R3及R2為式I中之C1-C6直鏈或分支 鏈烧基時,可為獨立取代基或其可連接在一起 以形成雙環結構,如下文所論證。Ri-NC-N-R2 Similarly, when R, R3 and R2 are C1-C6 straight or branched alkyl groups of formula I, they may be independent substituents or they may be joined together to form a bicyclic structure, As demonstrated below.

R1-N-Q-N-R2 選擇該等所揭示之前驅物之組態,以便使該反應性(尤 其是與H2〇)最佳化,且同時使該穩定性最佳化^ μ-N鍵 較弱且將快速地在該表面上起反應。同時,M-0鍵強得多 且將幫助使該分子穩定以避免快速分解。藉由調整此分 子’獲得前驅物,該前驅物由於較弱位點而在該基板上良 好地起反應。 當在式I中u= 1,χ=3,y=0且z=0時,及R2較佳為 Et或ipr ’ R3較佳為η、Me或NMe2,且R4較佳為C1-C4 13 201241224 直鏈或分支鏈烧基鏈。例示性前驅物包括: M(iPr-N-C(H)-N-iPr)!(OiPr)3 ' M(iPr-N-C(H)-N-iPr)i(OMe)3 ' M(iPr-N-C(H)-N-iPr)i(OEt)3、M(iPr-N-C(H)-N-iPr)!(OnPr)3、 M(iPr-N-C(H)-N-iPr)i(OsBu)3 ' M(iPr-N-C(H)-N-iPr)i(OiBu)3 ' M(iPr-N-C(H)-N-iPr)1(OtBu)3 ' M(iPr-N-C(Me)-N-iPr),(OiPr)3 ' M(iPr-N-C(Me)-N-iPr)i(OMe)3 ' M(iPr-N-C(Me)-N-iPr)i(OEt)3 ' M(iPr-N-C(Me)-N-iPr)i(OnPr)3 ' M(iPr-N-C(Me)-N-iPr)i(OsBu)3 ' M(iPr-N-C(Me)-N-iPr)i(OiBu)3 ' M(iPr-N-C(Me)-N-iPr)i(OtBu)3 ' M(Et-N-C(Me)-N-Et)!(OEt)3 、 M(Et-N-C(Me)-N-Et)i(OMe)3 、 M(Et-N-C(Me)-N-Et)i(OnPr)3 ' M(Et-N-C(Me)-N-Et)i(OsBu)3 ' MCEt-N-C^MehN-EQ^OiBuh、MiEt-N-C^MehN-EOKOtBuh,或 M(iPr-N-C(NMe2)-N-iPr)(OiPr)3 〇 當 M 為 Hf 時,該等例示性前驅物包括: Hf(iPr-N-C(H)-N-iPr)!(OiPr)3 ' Hf(iPr-N-C(H)-N-iPr)!(OMe)3 ' Hf(iPr-N-C(H)-N-iPr),(OEt)3、HfOPr-N-CTO-N-iPOKOnP^s ' Hf(iPr-N-C(H)-N-iPr)i(OsBu)3 ' Hf(iPr-N-C(H)-N-iPr)i(OiBu)3 ' Hf(iPr-N-C(H)-N-iPr)!(OtBu)3 ' Hf(iPr-N-C(Me)-N-iPr)i(OiPr)3 ' Hf(iPr-N-C(Me)-N-iPr)i(OMe)3 ' Hf(iPr-N-C(Me)-N-iPr),(OEt)3 ' Hf(iPr-N-C(Me)-N-iPr)i(OnPr)3' Hf(iPr-N-C(Me)-N-iPr)i(OsBu)3 ' Hf(iPr-N-C(Me)-N-iPr)i(OiBu)3' Hf(iPr-N-C(Me)-N-iPr)i(OtBu)3 ' Hf(Et-N-C(Me)-N-Et)i(OEt)3 ' Hf(Et-N-C(Me)-N-Et)!(OMe)3 、 Hf(Et-N-C(Me)-N-Et)!(OnPr)3 ' Hf(Et-N-C(Me)-N-Et)1(OsBu)3 ' HfXEt-N-C^MehN-EtMOiBuh、HfXEt-N-C^MehN-EtMOtBuh,或 Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)3。 14 201241224 • 當 Μ 為 Zr 時,該等例示性前驅物包括:R1-NQN-R2 selects the configuration of the precursors disclosed in order to optimize the reactivity (especially with H2〇) and at the same time optimize the stability ^ μ-N bond is weak It will react quickly on this surface. At the same time, the M-0 bond is much stronger and will help stabilize the molecule to avoid rapid decomposition. The precursor is obtained by adjusting this molecule, which precursor reacts well on the substrate due to the weaker sites. When u = 1, χ = 3, y = 0 and z = 0 in the formula I, and R2 is preferably Et or ipr ' R3 is preferably η, Me or NMe2, and R4 is preferably C1-C4 13 201241224 Linear or branched chain base chain. Exemplary precursors include: M(iPr-NC(H)-N-iPr)!(OiPr)3 ' M(iPr-NC(H)-N-iPr)i(OMe)3 ' M(iPr-NC( H)-N-iPr)i(OEt)3, M(iPr-NC(H)-N-iPr)!(OnPr)3, M(iPr-NC(H)-N-iPr)i(OsBu)3 ' M(iPr-NC(H)-N-iPr)i(OiBu)3 ' M(iPr-NC(H)-N-iPr)1(OtBu)3 ' M(iPr-NC(Me)-N- iPr),(OiPr)3 ' M(iPr-NC(Me)-N-iPr)i(OMe)3 ' M(iPr-NC(Me)-N-iPr)i(OEt)3 ' M(iPr- NC(Me)-N-iPr)i(OnPr)3 ' M(iPr-NC(Me)-N-iPr)i(OsBu)3 ' M(iPr-NC(Me)-N-iPr)i(OiBu ) 3 ' M(iPr-NC(Me)-N-iPr)i(OtBu)3 ' M(Et-NC(Me)-N-Et)!(OEt)3 , M(Et-NC(Me)- N-Et)i(OMe)3, M(Et-NC(Me)-N-Et)i(OnPr)3 ' M(Et-NC(Me)-N-Et)i(OsBu)3 ' MCEt- NC^MehN-EQ^OiBuh, MiEt-NC^MehN-EOKOtBuh, or M(iPr-NC(NMe2)-N-iPr)(OiPr)3 When M is Hf, the exemplary precursors include: Hf (iPr-NC(H)-N-iPr)!(OiPr)3 'Hf(iPr-NC(H)-N-iPr)!(OMe)3 ' Hf(iPr-NC(H)-N-iPr) ,(OEt)3,HfOPr-N-CTO-N-iPOKOnP^s 'Hf(iPr-NC(H)-N-iPr)i(OsBu)3 ' Hf(iPr-NC(H)-N-iPr) i(OiBu)3 ' Hf(iPr-NC(H)-N-iPr)!(OtBu)3 ' Hf(iPr-NC(Me)-N-iPr)i(OiPr)3 ' Hf(iPr-NC( Me)-N-iPr)i(OMe)3 ' Hf(iPr-NC(Me)-N -iPr),(OEt)3 'Hf(iPr-NC(Me)-N-iPr)i(OnPr)3' Hf(iPr-NC(Me)-N-iPr)i(OsBu)3 ' Hf(iPr -NC(Me)-N-iPr)i(OiBu)3' Hf(iPr-NC(Me)-N-iPr)i(OtBu)3 ' Hf(Et-NC(Me)-N-Et)i( OEt)3 ' Hf(Et-NC(Me)-N-Et)!(OMe)3 , Hf(Et-NC(Me)-N-Et)!(OnPr)3 ' Hf(Et-NC(Me) -N-Et)1(OsBu)3 'HfXEt-NC^MehN-EtMOiBuh, HfXEt-NC^MehN-EtMOtBuh, or Hf(iPr-NC(NMe2)-N-iPr)(OiPr)3. 14 201241224 • When Μ is Zr, these exemplary precursors include:

Zr(iPr-N-C(H)-N-iPr)!(OiPr)3 、Zr(iPr-N-C(H)-N-iPr),(OMe)3 、 Zr(iPr-N-C(H)-N-iPr)!(OEt)3 、Zr(iPr-N-C(H)-N-iPr)!(OnPr)3 、 Zr(iPr-N-C(H)-N-iPr)!(OsBu)3、Zr(iPr-N-C(H)-N-iPr)!(OiBu)3 ' Zr(iPr-N-C(H)-N-iPr)!(OtBu)3 ' Zr(iPr-N-C(Me)-N-iPr)i(OiPr)3 ' Zr(iPr-N-C(Me)-N-iPr)!(OMe)3 ' Zr(iPr-N-C(Me)-N-iPr)!(OEt)3 ' Zr(iPr-N-C(Me)-N-iPr)!(OnPr)3 ' Zr(iPr-N-C(Me)-N-iPr)i(OsBu)3 ' Zr(iPr-N-C(Me)-N-iPr)!(OiBu)3 ' Zr(iPr-N-C(Me)-N-iPr)!(OtBu)3 ' Zr(Et-N-C(Me)-N-Et)!(OEt)3 、Zr(Et-N-C(Me)-N-Et)i(OMe)3 、 Zr(Et-N-C(Me)-N-Et),(OnPr)3 ' Zr(Et-N-C(Me)-N-Et),(OsBu)3 ' Zi^Et-N-CXMeyN-EthCOiBuh、ZrCEt-N-C^MeVN-EOKOtBuh,或 Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)3。 在此具體實例中,該等較佳例示性前驅物為 HfCiPr-iN-C^MehN-iPOKOiPrh 或 ZrGPr-N-C^MeyN-iPrMOiPrh。 當在式 II 中 m=2 或 3,v=l,x=2,y=0 且 z = 0 時,I 及R2較佳為Et或iPr,R3較佳為Η,且R4較佳為C1-C4 直鏈或分支鍵燒基鏈。更佳地,當m=2時,R!及R2不為 Me。例示性前驅物包括:MCiPr-N-CCHzh-N-iPrhCOiPrh、 M(iPr-N-(CH2)2-N-iPr)i(OMe)2 > M(iPr-N-(CH2)2-N-iPr)i(OEt)2 ' M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)2-N-iPr)1(OsBu)2 ' M(iPr-N-(CH2)2-N-iPr)i(OiBu)2 ' M(iPr-N-(CH2)2-N-iPr)i(OtBu)2 ' M(Et-N-(CH2)2-N-Et)1(OiPr)2 、 M(Et-N-(CH2)2-N-Et),(OMe)2 、 M(Et-N-(CH2)2-N-Et)1(OEt)2 、 M(Et-N-(CH2)2-N-Et)1(OnPr)2 、 M(Et-N-(CH2)2-N-Et)i(OsBu)2 ' M(Et-N-(CH2)2-N-Et)1(OiBu)2 ' 15 Hit* 201241224 M(Et-N-(CH2)2-N-Et)1(OtBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr)i(OMe)2 ' M(iPr-N-(CH2)3-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)3-N-iPr)1(OsBu)2 ' M(iPr-N-(CH2)3-N-iPr)i(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr),(OtBu)2 ' M(Et-N-(CH2)3-N-Et),(OiPr)2 、 M(Et-N-(CH2)3-N-Et), (OMe)2 、 M(Et-N-(CH2)3-N-Et)i(OEt)2 、 M(Et-N-(CH2)3-N-Et)1(OnPr)2 、Zr(iPr-NC(H)-N-iPr)!(OiPr)3, Zr(iPr-NC(H)-N-iPr), (OMe)3, Zr(iPr-NC(H)-N-iPr )!(OEt)3 , Zr(iPr-NC(H)-N-iPr)!(OnPr)3 , Zr(iPr-NC(H)-N-iPr)!(OsBu)3, Zr(iPr-NC (H)-N-iPr)!(OiBu)3 ' Zr(iPr-NC(H)-N-iPr)!(OtBu)3 ' Zr(iPr-NC(Me)-N-iPr)i(OiPr) 3 ' Zr(iPr-NC(Me)-N-iPr)!(OMe)3 ' Zr(iPr-NC(Me)-N-iPr)!(OEt)3 ' Zr(iPr-NC(Me)-N -iPr)!(OnPr)3 ' Zr(iPr-NC(Me)-N-iPr)i(OsBu)3 ' Zr(iPr-NC(Me)-N-iPr)!(OiBu)3 ' Zr(iPr -NC(Me)-N-iPr)!(OtBu)3 ' Zr(Et-NC(Me)-N-Et)!(OEt)3 , Zr(Et-NC(Me)-N-Et)i( OMe)3, Zr(Et-NC(Me)-N-Et), (OnPr)3 ' Zr(Et-NC(Me)-N-Et), (OsBu)3 ' Zi^Et-N-CXMeyN- EthCOiBuh, ZrCEt-NC^MeVN-EOKOtBuh, or Zr(iPr-NC(NMe2)-N-iPr)(OiPr)3. In this particular embodiment, the preferred exemplary precursors are HfCiPr-iN-C^MehN-iPOKOiPrh or ZrGPr-N-C^MeyN-iPrMOiPrh. When m=2 or 3, v=l, x=2, y=0 and z=0 in formula II, I and R2 are preferably Et or iPr, R3 is preferably Η, and R4 is preferably C1. -C4 linear or branched bond base chain. More preferably, when m = 2, R! and R2 are not Me. Exemplary precursors include: MCiPr-N-CCHzh-N-iPrhCOiPrh, M(iPr-N-(CH2)2-N-iPr)i(OMe)2 > M(iPr-N-(CH2)2-N -iPr)i(OEt)2 ' M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)2-N-iPr)1(OsBu)2 ' M(iPr-N-(CH2)2-N-iPr)i(OiBu)2 ' M(iPr-N-(CH2)2-N-iPr)i(OtBu)2 ' M(Et-N-( CH2)2-N-Et)1(OiPr)2, M(Et-N-(CH2)2-N-Et), (OMe)2, M(Et-N-(CH2)2-N-Et) 1(OEt)2 , M(Et-N-(CH2)2-N-Et)1(OnPr)2 , M(Et-N-(CH2)2-N-Et)i(OsBu)2 ' M( Et-N-(CH2)2-N-Et)1(OiBu)2 ' 15 Hit* 201241224 M(Et-N-(CH2)2-N-Et)1(OtBu)2 ' M(iPr-N- (CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr)i(OMe)2 ' M(iPr-N-(CH2)3-N-iPr )1(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)3-N-iPr)1(OsBu)2 ' M (iPr-N-(CH2)3-N-iPr)i(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr), (OtBu)2 ' M(Et-N-(CH2) 3-N-Et), (OiPr)2, M(Et-N-(CH2)3-N-Et), (OMe)2, M(Et-N-(CH2)3-N-Et)i( OEt)2, M(Et-N-(CH2)3-N-Et)1(OnPr)2,

Mpt-N-CCHA-N-EthCOsBuh、MCEt-N-CCHA-N-EthCOiBuh,或 JV^Et-NJCHA-N-EtMOtBuh。 當 M 為 Hf 時,該等例示性前驅物包括: Hf(iPr-N-(CH2)2-N-iPr),(OiPr)2 ' Hf(iPr-N-(CH2)2-N-iPr)1(OMe)2 ' Hf(iPr-N-(CH2)2-N-iPr)1(OEt)2 ' Hf(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' Hf(iPr-N-(CH2)2-N-iPr),(OsBu)2 ' Hf(iPr-N-(CH2)2-N-iPr)i(OiBu)2 ' Hf(iPr-N-(CH2)2-N-iPr)i(OtBu)2 ' Hf(Et-N-(CH2)2-N-Et),(OiPr)2 ' Hf(Et-N-(CH2)2-N-Et),(OMe)2 、 Hf(Et-N-(CH2)2-N-Et)1(OEt)2 、Mpt-N-CCHA-N-EthCOsBuh, MCEt-N-CCHA-N-EthCOiBuh, or JV^Et-NJCHA-N-EtMOtBuh. When M is Hf, the exemplary precursors include: Hf(iPr-N-(CH2)2-N-iPr), (OiPr)2 'Hf(iPr-N-(CH2)2-N-iPr) 1(OMe)2 'Hf(iPr-N-(CH2)2-N-iPr)1(OEt)2 'Hf(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' Hf( iPr-N-(CH2)2-N-iPr),(OsBu)2 'Hf(iPr-N-(CH2)2-N-iPr)i(OiBu)2 'Hf(iPr-N-(CH2)2 -N-iPr)i(OtBu)2 'Hf(Et-N-(CH2)2-N-Et), (OiPr)2 'Hf(Et-N-(CH2)2-N-Et), (OMe 2, Hf(Et-N-(CH2)2-N-Et)1(OEt)2,

Hf(Et-N-(CH2)2-N-Et)1(OnPr)2 ' Hf(Et-N-(CH2)2-N-Et)1(OsBu)2 'Hf(Et-N-(CH2)2-N-Et)1(OnPr)2 'Hf(Et-N-(CH2)2-N-Et)1(OsBu)2 '

Hf(Et-N-(CH2)2-N-Et)1(OiBu)2、 Hf(iPr-N-(CH2)3-N-iPr)1(OiPr)2、 Hf(iPr-N-(CH2)3-N-iPr)1(OEt)2 ' Hf(iPr-N-(CH2)3-N-iPr)1(OsBu)2 Hf(iPr-N-(CH2)3-N-iPr),(OtBu)2 Hf(Et-N-(CH2)3-N-Et)i(OMe)2 、 Hf(Et-N-(CH2)3-N-Et)i(OnPr)2 'Hf(Et-N-(CH2)2-N-Et)1(OiBu)2, Hf(iPr-N-(CH2)3-N-iPr)1(OiPr)2, Hf(iPr-N-(CH2) )3-N-iPr)1(OEt)2 'Hf(iPr-N-(CH2)3-N-iPr)1(OsBu)2 Hf(iPr-N-(CH2)3-N-iPr), ( OtBu)2 Hf(Et-N-(CH2)3-N-Et)i(OMe)2 , Hf(Et-N-(CH2)3-N-Et)i(OnPr)2 '

Hf(Et-N-(CH2)2-N-Et)i(OtBu)2 Hf(iPr-N-(CH2)3-N-iPr)1(OMe)2 Hf(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' Hf(iPr-N-(CH2)3-N-iPr)i(OiBu) > Hf(Et-N-(CH2)3-N-Et)i(OiPr)2 Hf(Et-N-(CH2)3-N-Et)1(OEt)2 Hf(Et-N-(CH2)3-N-Et)1(OsBu)2Hf(Et-N-(CH2)2-N-Et)i(OtBu)2 Hf(iPr-N-(CH2)3-N-iPr)1(OMe)2 Hf(iPr-N-(CH2)3 -N-iPr)1(OnPr)2 'Hf(iPr-N-(CH2)3-N-iPr)i(OiBu) > Hf(Et-N-(CH2)3-N-Et)i(OiPr 2 Hf(Et-N-(CH2)3-N-Et)1(OEt)2 Hf(Et-N-(CH2)3-N-Et)1(OsBu)2

Hf^Et-N-CCHA-N-EtMOiBuh,或 HiXEt-NJCHA-N-EtMOtBuh。 當 M 為 Zr 時,該等例示性前驅物包括: 16 201241224Hf^Et-N-CCHA-N-EtMOiBuh, or HiXEt-NJCHA-N-EtMOtBuh. When M is Zr, the exemplary precursors include: 16 201241224

Zr(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OMe)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OEt)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OsBu)2' Zr(iPr-N-(CH2)2-N-iPr)1(OiBu)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OtBu)2 ' Zr(Et-N-(CH2)2-N-Et)1(OiPr)2 ' Zr(Et-N-(CH2)2-N-Et)1(OMe)2 、Zr(Et-N-(CH2)2-N-Et),(OEt)2 、 Zr(Et-N-(CH2)2-N-Et)1(OnPr)2 ' Zr(Et-N-(CH2)2-N-Et)i(OsBu)2 ' Zr(Et-N-(CH2)2-N-Et)1(OiBu)2 ' Zr(Et-N-(CH2)2-N-Et)1(OtBu)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OMe)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OEt)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' Zr(iPr-N-(CH2)3-N-iPr),(OsBu)2' Zr(iPr-N-(CH2)3-N-iPr)1(OiBu)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OtBu)2 > Zr(Et-N-(CH2)3-N-Et)i(OiPr)2 ' Zr(Et-N-(CH2)3-N-Et)1(OMe)2 、Zr(Et-N-(CH2)3-N-Et)1(OEt)2 、 Zi^Et-N-CCHzh-N-EthCOnPrh、ZrCEt-NJCHA-N-EtMOsBuh、 ZKEt-N-CCHA-N-EtMOiBuh,或 ZMEt-N-CCH^-N-EtMOtBuh。 在此具體實例中,該等較佳例示性前驅物為: Hf(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' Hf(Et-N-(CH2)3-N-Et)1(OiPr)2 ' Hf(Et-N-(CH2)2-N-Et)1(OiPr)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' Zi^Et-N-CCH^-N-EthCOiPrh,或 Zi^Et-N-CCHdrN-EthCOiPrh。 當在式I中u=2,x=2,y=0且z = 0時,該前驅物具有 以下化學結構:Zr(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OMe)2 ' Zr(iPr-N-(CH2 )2-N-iPr)1(OEt)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' Zr(iPr-N-(CH2)2-N-iPr)1 (OsBu)2' Zr(iPr-N-(CH2)2-N-iPr)1(OiBu)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OtBu)2 ' Zr(Et -N-(CH2)2-N-Et)1(OiPr)2 ' Zr(Et-N-(CH2)2-N-Et)1(OMe)2 , Zr(Et-N-(CH2)2- N-Et), (OEt)2, Zr(Et-N-(CH2)2-N-Et)1(OnPr)2 ' Zr(Et-N-(CH2)2-N-Et)i(OsBu) 2 ' Zr(Et-N-(CH2)2-N-Et)1(OiBu)2 ' Zr(Et-N-(CH2)2-N-Et)1(OtBu)2 ' Zr(iPr-N- (CH2)3-N-iPr)1(OiPr)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OMe)2 ' Zr(iPr-N-(CH2)3-N-iPr )1(OEt)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' Zr(iPr-N-(CH2)3-N-iPr), (OsBu)2' Zr (iPr-N-(CH2)3-N-iPr)1(OiBu)2 ' Zr(iPr-N-(CH2)3-N-iPr)1(OtBu)2 > Zr(Et-N-(CH2 )3-N-Et)i(OiPr)2 ' Zr(Et-N-(CH2)3-N-Et)1(OMe)2 , Zr(Et-N-(CH2)3-N-Et)1 (OEt)2, Zi^Et-N-CCHzh-N-EthCOnPrh, ZrCEt-NJCHA-N-EtMOsBuh, ZKEt-N-CCHA-N-EtMOiBuh, or ZMEt-N-CCH^-N-EtMOtBuh. In this particular example, the preferred exemplary precursors are: Hf(iPr-N-(CH2)2-N-iPr)1(OiPr)2' Hf(Et-N-(CH2)3-N- Et)1(OiPr)2 'Hf(Et-N-(CH2)2-N-Et)1(OiPr)2 ' Zr(iPr-N-(CH2)2-N-iPr)1(OiPr)2 ' Zi^Et-N-CCH^-N-EthCOiPrh, or Zi^Et-N-CCHdrN-EthCOiPrh. When u = 2, x = 2, y = 0 and z = 0 in formula I, the precursor has the following chemical structure:

17 201241224 在此具體實例中,R,及R2較佳為Et或iPr,R3較佳為 Η或Me,且R4較佳為C1-C4直鏈或分支鏈烷基鏈。更佳 地,R_3不為 NMe2 。 例示性前驅物包括 : M(iPr-N-C(H)-N-iPr)2(OiPr)2、M(iPr-N-C(H)-N-iPr)2(OMe)2、 M(iPr-N-C(H)-N-iPr)2(OEt)2、M(iPr-N-C(H)-N-iPr)2(OnPr)2、 M(iPr-N-C(H)-N-iPr)2(OsBu)2、M(iPr-N-C(H)-N-iPr)2(OiBu)2、 M(iPr-N-C(H)-N-iPr)2(OtBu)2、M(Et-N-C(H)-N-Et)2(OiPr)2、 M(Et-N-C(H)-N-Et)2(OMe)2 、 M(Et-N-C(H)-N-Et)2(〇Et)2 、 M(Et-N-C(H)-N-Et)2(OnPr)2、M(Et-N-C(H)-N-Et)2(〇sBu)2、 M(Et-N-C(H)-N-Et)2(OiBu)2、M(Et-N-C(H)-N-Et)2(OtBu)2、 M(iPr-N-C(Me)-N-iPr)2(OiPr)2、M(iPr-N-C(Me)-N-iPr)2(OMe)2、 M(iPr-N-C(Me)-N_iPr)2(OEt)2、M(iPr_N-C(Me)-N-iPr)2(OnPr)2、 M(iPr-N-C(Me)-N-iPr)2(OsBu)2、M(iPr-N-C(Me)-N-iPr)2(OiBu)2、 M(iPr-N-C(Me)-N-iPr)2(OtBu)2、M(Et-N-C(Me)-N-Et)2(OiPr)2 ' M(Et-N-C(Me)-N-Et)2(OMe)2 、M(Et-N-C(Me)-N-Et)2(〇Et)2 、 M(Et-N-C(Me)-N-Et)2(OnPr)2、M(Et-N-C(Me)-N-Et)2(OsBu)2、 M(Et-N-C(Me)-N-Et)2(OiBu)2,及 M(Et-N-C(Me)-N-Et)2(OtBu)2。 當 M 為 Hf 時,該等例示性前驅物包括: Hf(iPr-N-C(H)-N-iPr)2(OiPr)2 ' Hf(iPr-N-C(H)-N-iPr)2(OMe)2、 Hf(iPr-N-C(H)-N-iPr)2(OEt)2、Hf(iPr-N-C(H)-N-iPr)2(OnPr)2、 Hf(iPr-N-C(H)-N-iPr)2(OsBu)2、Hf(iPr-N-C(H)-N-iPr)2(OiBu)2 ' Hf(iPr-N-C(H)-N-iPr)2(OtBu)2、Hf(Et-N-C(H)-N-Et)2(OiPr)2、 Hf(Et-N-C(H)-N-Et)2(OMe)2 、 Hf(Et-N-C(H)-N-Et)2(〇Et)2 、 20124122417 201241224 In this embodiment, R, and R2 are preferably Et or iPr, R3 is preferably Η or Me, and R4 is preferably a C1-C4 linear or branched alkyl chain. More preferably, R_3 is not NMe2. Exemplary precursors include: M(iPr-NC(H)-N-iPr)2(OiPr)2, M(iPr-NC(H)-N-iPr)2(OMe)2, M(iPr-NC( H)-N-iPr)2(OEt)2, M(iPr-NC(H)-N-iPr)2(OnPr)2, M(iPr-NC(H)-N-iPr)2(OsBu)2 , M(iPr-NC(H)-N-iPr)2(OiBu)2, M(iPr-NC(H)-N-iPr)2(OtBu)2, M(Et-NC(H)-N- Et)2(OiPr)2, M(Et-NC(H)-N-Et)2(OMe)2, M(Et-NC(H)-N-Et)2(〇Et)2, M(Et -NC(H)-N-Et)2(OnPr)2, M(Et-NC(H)-N-Et)2(〇sBu)2, M(Et-NC(H)-N-Et)2 (OiBu)2, M(Et-NC(H)-N-Et)2(OtBu)2, M(iPr-NC(Me)-N-iPr)2(OiPr)2, M(iPr-NC(Me )-N-iPr)2(OMe)2, M(iPr-NC(Me)-N_iPr)2(OEt)2, M(iPr_N-C(Me)-N-iPr)2(OnPr)2, M( iPr-NC(Me)-N-iPr)2(OsBu)2, M(iPr-NC(Me)-N-iPr)2(OiBu)2, M(iPr-NC(Me)-N-iPr)2 (OtBu)2, M(Et-NC(Me)-N-Et)2(OiPr)2 'M(Et-NC(Me)-N-Et)2(OMe)2, M(Et-NC(Me )-N-Et)2(〇Et)2, M(Et-NC(Me)-N-Et)2(OnPr)2, M(Et-NC(Me)-N-Et)2(OsBu)2 M(Et-NC(Me)-N-Et)2(OiBu)2, and M(Et-NC(Me)-N-Et)2(OtBu)2. When M is Hf, the exemplary precursors include: Hf(iPr-NC(H)-N-iPr)2(OiPr)2 'Hf(iPr-NC(H)-N-iPr)2(OMe) 2. Hf(iPr-NC(H)-N-iPr)2(OEt)2, Hf(iPr-NC(H)-N-iPr)2(OnPr)2, Hf(iPr-NC(H)-N -iPr)2(OsBu)2, Hf(iPr-NC(H)-N-iPr)2(OiBu)2 'Hf(iPr-NC(H)-N-iPr)2(OtBu)2, Hf(Et -NC(H)-N-Et)2(OiPr)2, Hf(Et-NC(H)-N-Et)2(OMe)2, Hf(Et-NC(H)-N-Et)2( 〇Et)2, 201241224

Hf(Et-N-C(H)-N-Et)2(OnPr)2 、 Hf(Et-N-C(H)-N-Et)2(〇sBu)2 、 Hf(Et-N-C(H)-N-Et)2(OiBu)2 、 Hf(Et-N-C(H)-N-Et)2(〇tBu)2 、 Hf(iPr-N-C(Me)-N-iPr)2(OiPr)2、Hf(iPr-N-C(Me)-N-iPr)2(OMe)2、 Hf(iPr-N-C(Me)-N-iPr)2(OEt)2、Hf(iPr-N-C(Me)-N-iPr)2(OnPr)2、 Hf(iPr-N-C(Me)-N-iPr)2(OsBu)2、Hf(iPr-N-C(Me)-N-iPr)2(OiBu)2、 Hf(iPr-N-C(Me)-N-iPr)2(OtBu)2、Hf(Et-N-C(Me)-N-Et)2(OiPr)2、 Hf(Et-N-C(Me)-N-Et)2(OMe)2 、 Hf(Et-N-C(Me)-N-Et)2(〇Et)2 、 Hf(Et-N-C(Me)-N-Et)2(OnPr)2、Hf(Et-N-C(Me)-N-Et)2(OsBu)2、 Hf(Et-N-C(Me)-N-Et)2(OiBu)2,及 Hf(Et-N-C(Me)-N-Et)2(OtBu)2。 當 M 為 Zr 時,該等例示性前驅物包括: Zr(iPr-N-C(H)-N-iPr)2(OiPr)2 、Zr(iPr-N-C(H)-N-iPr)2(OMe)2 、 Zr(iPr-N-C(H)-N-iPr)2(OEt)2、Zr(iPr-N-C(H)-N-iPr)2(OnPr)2、 Zr(iPr-N-C(H)-N-iPr)2(OsBu)2 ' Zr(iPr-N-C(H)-N-iPr)2(OiBu)2 ' < Zr(iPr-N-C(H)-N-iPr)2(OtBu)2、Zr(Et_N-C(H)-N-Et)2(OiPr)2、 Zr(Et-N-C(H)-N-Et)2(OMe)2 、 Zr(Et-N-C(H)-N-Et)2(OEt)2 、 Zr(Et-N-C(H)-N-Et)2(OnPr)2 、 Zr(Et-N-C(H)-N-Et)2(OsBu)2 、 Zr(Et-N-C(H)-N-Et)2(〇iBu)2 、Zr(Et-N-C(H)-N-Et)2(〇tBu)2 、 Zr(iPr-N-C(Me)-N-iPr)2(OiPr)2 ' Zr(iPr-N-C(Me)-N-iPr)2(OMe)2 ' Zr(iPr-N-C(Me)-N-iPr)2(〇Et)2 ' Zr(iPr-N-C(Me)-N-iPr)2(OnPr)2 > Zr(iPr-N-C(Me)-N-iPr)2(OsBu)2、Zr(iPr-N-C(Me)-N-iPr)2(OiBu)2、 Zr(iPr-N-C(Me)-N-iPr)2(OtBu)2、Zr(Et-N-C(Me)-N-Et)2(OiPr)2、 Zr(Et-N-C(Me)-N-Et)2(OMe)2 、Zr(Et-N-C(Me)-N-Et)2(OEt)2 、 Zr(Et-N-C(Me)-N-Et)2(OnPr)2、Zr(Et-N-C(Me)-N-Et)2(OsBu)2、 Zr(Et-N-C(Me)-N-Et)2(OiBu)2,及 Zr(Et-N-C(Me)-N-Et)2(OtBu)2。 19 201241224 在此具體實例中,該較佳例示性前驅物為 Hf(iPr-N-C(H)-N-iPr)2(OiPr)2、Hf(iPr-N-C(Me)-N-iPr)2(OiPr)2、 Zr(iPr-N-C(H)-N-iPr)2(OiPr)2,或 Zr(iPr-N-C(Me)-N-iPr)2(OiPr)2。 當在式I中u= 1 ’ x = 2 ’ y= 1且z = 0時,該前驅物具有 以下化學結構:Hf(Et-NC(H)-N-Et)2(OnPr)2, Hf(Et-NC(H)-N-Et)2(〇sBu)2, Hf(Et-NC(H)-N- Et)2(OiBu)2, Hf(Et-NC(H)-N-Et)2(〇tBu)2, Hf(iPr-NC(Me)-N-iPr)2(OiPr)2, Hf(iPr -NC(Me)-N-iPr)2(OMe)2, Hf(iPr-NC(Me)-N-iPr)2(OEt)2, Hf(iPr-NC(Me)-N-iPr)2( OnPr)2, Hf(iPr-NC(Me)-N-iPr)2(OsBu)2, Hf(iPr-NC(Me)-N-iPr)2(OiBu)2, Hf(iPr-NC(Me) -N-iPr)2(OtBu)2, Hf(Et-NC(Me)-N-Et)2(OiPr)2, Hf(Et-NC(Me)-N-Et)2(OMe)2, Hf (Et-NC(Me)-N-Et)2(〇Et)2, Hf(Et-NC(Me)-N-Et)2(OnPr)2, Hf(Et-NC(Me)-N-Et 2(OsBu)2, Hf(Et-NC(Me)-N-Et)2(OiBu)2, and Hf(Et-NC(Me)-N-Et)2(OtBu)2. When M is Zr, the exemplary precursors include: Zr(iPr-NC(H)-N-iPr)2(OiPr)2, Zr(iPr-NC(H)-N-iPr)2(OMe) 2, Zr(iPr-NC(H)-N-iPr)2(OEt)2, Zr(iPr-NC(H)-N-iPr)2(OnPr)2, Zr(iPr-NC(H)-N -iPr)2(OsBu)2 ' Zr(iPr-NC(H)-N-iPr)2(OiBu)2 ' < Zr(iPr-NC(H)-N-iPr)2(OtBu)2, Zr (Et_N-C(H)-N-Et)2(OiPr)2, Zr(Et-NC(H)-N-Et)2(OMe)2, Zr(Et-NC(H)-N-Et) 2(OEt)2, Zr(Et-NC(H)-N-Et)2(OnPr)2, Zr(Et-NC(H)-N-Et)2(OsBu)2, Zr(Et-NC( H)-N-Et)2(〇iBu)2, Zr(Et-NC(H)-N-Et)2(〇tBu)2, Zr(iPr-NC(Me)-N-iPr)2(OiPr 2' Zr(iPr-NC(Me)-N-iPr)2(OMe)2 ' Zr(iPr-NC(Me)-N-iPr)2(〇Et)2 ' Zr(iPr-NC(Me) -N-iPr)2(OnPr)2 > Zr(iPr-NC(Me)-N-iPr)2(OsBu)2, Zr(iPr-NC(Me)-N-iPr)2(OiBu)2 Zr(iPr-NC(Me)-N-iPr)2(OtBu)2, Zr(Et-NC(Me)-N-Et)2(OiPr)2, Zr(Et-NC(Me)-N-Et 2(OMe)2, Zr(Et-NC(Me)-N-Et)2(OEt)2, Zr(Et-NC(Me)-N-Et)2(OnPr)2, Zr(Et-NC (Me)-N-Et)2(OsBu)2, Zr(Et-NC(Me)-N-Et)2(OiBu)2, and Zr(Et-NC(Me)-N-Et)2(OtBu )2. 19 201241224 In this particular example, the preferred exemplary precursor is Hf(iPr-NC(H)-N-iPr)2(OiPr)2, Hf(iPr-NC(Me)-N-iPr)2 ( OiPr)2, Zr(iPr-NC(H)-N-iPr)2(OiPr)2, or Zr(iPr-NC(Me)-N-iPr)2(OiPr)2. When u = 1 ' x = 2 ' y = 1 and z = 0 in the formula I, the precursor has the following chemical structure:

在此具體實例中,Ri及R2較佳為Et或iPr ; I較佳為 Η、Me或NMe2 ; R4較佳為iPr ;且R5及R6較佳獨立為Me 或 Et 。 例 示 性 前 驅 物包括 : M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NMe2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEt2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2) 、 201241224 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2) M(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) 及 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr)。 當 M 為 Hf 時,該等例示性前驅物包括: Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) 、In this embodiment, Ri and R2 are preferably Et or iPr; I is preferably Η, Me or NMe2; R4 is preferably iPr; and R5 and R6 are preferably independently Me or Et. Exemplary precursors include: M(iPr-NC(Me)-N-iPr)(OiPr)2(NMe2), M(iPr-NC(Me)-N-iPr)(OiPr)2(NEt2), M( iPr-NC(Me)-N-iPr)(OiPr)2(NEtMe), M(Et-NC(Me)-N-Et)(OiPr)2(NMe2), M(Et-NC(Me)-N -Et)(OiPr)2(NEt2) , M(Et-NC(Me)-N-Et)(OiPr)2(NEtMe) , M(iPr-NC(NMe2)-N-iPr)(OiPr)2( NMe2), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NEt2), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NEtMe), M(iPr-NC (Me)-N-iPr)(OiPr)2(NMeiPr), M(iPr-NC(Me)-N-iPr)(OiPr)2(NiPr2), 201241224 M(iPr-NC(Me)-N-iPr )(OiPr)2(NMetBu) , M(iPr-NC(Me)-N-iPr)(OiPr)2(NneoPentyl2) M(Et-NC(Me)-N-Et)(OiPr)2(NMeiPr) , M(Et-NC(Me)-N-Et)(OiPr)2(NiPr2), M(Et-NC(Me)-N-Et)(OiPr)2(NneoPentyl2), M(iPr-NC(NMe2) -N-iPr)(OiPr)2(NMeiPr), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NiPr2), M(iPr-NC(NMe2)-N-iPr)(OiPr) 2 (NneoPentyl2) and M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMeiPr). When M is Hf, the exemplary precursors include: Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2),

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2) 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2),

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe) 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe),

Hf(Et-N-C(Me)-N-Et)(OiPr)2(NMe2) 、Hf(Et-N-C(Me)-N-Et)(OiPr)2(NMe2),

Hf(Et-N-C(Me)-N-Et)(OiPr)2(NEt2) 、Hf(Et-N-C(Me)-N-Et)(OiPr)2(NEt2),

Hf(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe) 、Hf(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe),

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2) 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2),

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2) 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2),

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe) 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe),

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr) 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr),

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2) 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2),

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu) 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu),

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2) 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2),

Hf(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr) 、 21 201241224Hf(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr), 21 201241224

Hf(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2) 、Hf(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2),

Hf(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2) 、Hf(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2),

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr) 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr),

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2) 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2),

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) 及Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) and

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr)。 當 M 為 Zr 時,該等例示性前驅物包括: Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)2 (NMeiPr). When M is Zr, the exemplary precursors include: Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2),

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2) 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2),

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe) 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe),

Zr(Et-N-C(Me)-N-Et)(OiPr)2(NMe2) 、Zr(Et-N-C(Me)-N-Et)(OiPr)2(NMe2),

Zr(Et-N-C(Me)-N-Et)(OiPr)2(NEt2) 、Zr(Et-N-C(Me)-N-Et)(OiPr)2(NEt2),

Zr(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe) 、Zr(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe),

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2) 、Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2),

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2) 、Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2),

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe) 、Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe),

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr) 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr),

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2) 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2),

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu) 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu),

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2) 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2),

Zr(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr) 、Zr(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr),

Zr(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2) 、Zr(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2),

Zr(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2) 、Zr(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2),

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr) 、 22 201241224Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr) , 22 201241224

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2) 、Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2),

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) , 及 Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr)。 在此具體實例中,該較佳例示性前驅物為Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2), and Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr). In this particular example, the preferred exemplary precursor is

Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) 或Hf(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) or

Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2)。 當在式I中u= 1,x=2,y=0且z= 1時,該前驅物具有 以下化學結構:Zr(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2). When in the formula I, u = 1, x = 2, y = 0 and z = 1, the precursor has the following chemical structure:

QR4QR4

OR4 在此具體實例中,Ri及R2較佳為Et或iPr ; R3較佳為 Η或Me ; R4較佳為iPr ;且R7較佳為Me。例示性前驅物 包 括 : M(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) 及 M(Et-N-C(Me)-N-Et)(0iPr)2(02CMe)。當 Μ 為 Hf 時,該等 例示性前驅物包括:Hf(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) 及 Hf(Et-N-C(Me)-N-Et)(0iPr)2(02CMe)。當 Μ 為 Zr 時,該 等例示性前驅物包括:Zr(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) 及 Zr(Et-N-C(Me)-N-Et)(0iPr)2(02CMe)。 當在式II中v=l,x=l,y=0且z = 1時,該前驅物 具有以下化學結構: 23 201241224OR4 In this embodiment, Ri and R2 are preferably Et or iPr; R3 is preferably Η or Me; R4 is preferably iPr; and R7 is preferably Me. Exemplary precursors include: M(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) and M(Et-N-C(Me)-N-Et)(0iPr)2(02CMe). When Μ is Hf, the exemplary precursors include: Hf(iPr-NC(Me)-N-iPr)(0iPr)2(02CMe) and Hf(Et-NC(Me)-N-Et) (0iPr) ) 2 (02CMe). When Μ is Zr, the exemplary precursors include: Zr(iPr-NC(Me)-N-iPr)(0iPr)2(02CMe) and Zr(Et-NC(Me)-N-Et) (0iPr) ) 2 (02CMe). When v = l, x = 1, y = 0 and z = 1 in formula II, the precursor has the following chemical structure: 23 201241224

I Ri 當 m=2,v=l,χ = 1,y=0,z=l 且 R_3=H 時,該前驅物 具有以下化學結構:I Ri When m=2, v=l, χ = 1, y=0, z=l and R_3=H, the precursor has the following chemical structure:

r2 IR2 I

Ri 當m=3,v=l,x=l,y=0,z=l且R3 = H日夺,該前驅物 具有以下化學結構:Ri When m=3, v=l, x=l, y=0, z=l and R3 = H, the precursor has the following chemical structure:

在此等具體實例中,m較佳為2或3,R!及R2較佳為 Et或iPr ; R3較佳為Η ; R4較佳為C1-C4直鏈或分支鏈烷 24 201241224 前驅物包括 基鍵;且 R7較佳為 Me。例示性 M(iPr-N-(CH2)2-N-iPr)(0iPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(OiBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) M(Et-N-(CH2)2-N-Et)(OiPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0Me)(02CMe) M(Et-N-(CH2)2-N-Et)(0Et)(02CMe) M(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0sBu)(02CMe) , 及 前驅物包括: M(Et-N-(CH2)2-N-Et)(OiBu)(02CMe) M(Et-N-(CH2)2-N-Et)(0tBu)(02CMe)。 當 M 為 Hf 時,該等例示性 Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(OtBu)(02CMe) Hf(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) 25 201241224In these specific examples, m is preferably 2 or 3, R! and R2 are preferably Et or iPr; R3 is preferably Η; R4 is preferably C1-C4 straight or branched alkane 24 201241224 precursor includes Base bond; and R7 is preferably Me. Illustrative M(iPr-N-(CH2)2-N-iPr)(0iPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) M(iPr-N- (CH2)2-N-iPr)(0Et)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) M(iPr-N-(CH2)2-N-iPr )(0sBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(OiBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) M (Et-N-(CH2)2-N-Et)(OiPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0Me)(02CMe) M(Et-N-(CH2) 2-N-Et)(0Et)(02CMe) M(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0sBu (02CMe), and the precursors include: M(Et-N-(CH2)2-N-Et)(OiBu)(02CMe) M(Et-N-(CH2)2-N-Et)(0tBu)( 02CMe). When M is Hf, the exemplary Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(02CMe)Hf(iPr-N-(CH2)2-N-iPr)(0Me)( 02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) Hf(iPr-N- (CH2)2-N-iPr)(0sBu)(02CMe) Hf(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe) Hf(iPr-N-(CH2)2-N-iPr )(OtBu)(02CMe) Hf(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) 25 201241224

Hf(Et-N-(CH2)2-N-Et)(0Me)(02CMe)Hf(Et-N-(CH2)2-N-Et)(0Me)(02CMe)

Hf(Et-N-(CH2)2-N-Et)(0Et)(02CMe)Hf(Et-N-(CH2)2-N-Et)(0Et)(02CMe)

Hf(Et-N-(CH2)2-N-Et)(0nPr)(02CMe)Hf(Et-N-(CH2)2-N-Et)(0nPr)(02CMe)

Hf(Et-N-(CH2)2-N-Et)(OsBu)(02CMe) , 及 驅物包括 :Hf(Et-N-(CH2)2-N-Et)(OsBu)(02CMe) , and the drive include:

Hf(Et-N-(CH2)2-N-Et)(OiBu)(02CMe)Hf(Et-N-(CH2)2-N-Et)(OiBu)(02CMe)

Hf(Et-N-(CH2)2-N-Et)(0tBu)(02CMe)。 當 M 為 Zr 時,該等例示性前 Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(02CMe) Zr(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) Zr(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe)Hf(Et-N-(CH2)2-N-Et) (0tBu) (02CMe). When M is Zr, the exemplary pre-Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(02CMe) Zr(iPr-N-(CH2)2-N-iPr)(0Me) (02CMe) Zr(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe)

Zr(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe)Zr(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe)

Zr(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe)Zr(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe)

Zr(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe)Zr(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe)

Zr(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe)Zr(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe)

Zr(Et-N-(CH2)2-N-Et)(OiPr)(02CMe)Zr(Et-N-(CH2)2-N-Et)(OiPr)(02CMe)

Zr(Et-N-(CH2)2-N-Et)(0Me)(02CMe) , 及 ,例示性前驅物 (NMe2)2 、Zr(Et-N-(CH2)2-N-Et)(0Me)(02CMe), and , an exemplary precursor (NMe2)2,

Zr(Et-N-(CH2)2-N-Et)(0Et)(02CMe) Zr(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) Zr(Et-N-(CH2)2-N-Et)(0sBu)(02CMe) Zr(Et-N-(CH2)2-N-Et)(0iBu)(02CMe) Zr(Et-N-(CH2)2-N-Et)(OtBu)(02CMe)。 當在式I中u=l,x=l,y=2且z = 0時 包 括 : M(iPr-N-C(Me)-N-iPr)(OiPr) M(iPr-N-C(Me)-N-iPr)(OiPr)(NEt2)2 26 201241224 M(iPr-N-C(Me)-N-iPr)(OiPr)(NEtMe)2 M(Et-N-C(Me)-N-Et)(OiPr)(NMe2)2 M(Et-N-C(Me)-N-Et)(OiPr)(NEt2)2 M(Et-N-C(Me)-N-Et)(OiPr)(NEtMe)2 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)(NMe2)2 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEt2)2 , 及 M(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEtMe)2。 當 M 為 Hf 時,該等例示性前驅物包括: Hf(iPr-N-C(Me)-N-iPr)(OiPr) (NMe2)2 、Zr(Et-N-(CH2)2-N-Et)(0Et)(02CMe) Zr(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) Zr(Et-N-(CH2) ) 2-N-Et)(0sBu)(02CMe) Zr(Et-N-(CH2)2-N-Et)(0iBu)(02CMe) Zr(Et-N-(CH2)2-N-Et)( OtBu) (02CMe). When u=l, x=l, y=2 and z=0 in the formula I, it includes: M(iPr-NC(Me)-N-iPr)(OiPr) M(iPr-NC(Me)-N- iPr)(OiPr)(NEt2)2 26 201241224 M(iPr-NC(Me)-N-iPr)(OiPr)(NEtMe)2 M(Et-NC(Me)-N-Et)(OiPr)(NMe2) 2 M(Et-NC(Me)-N-Et)(OiPr)(NEt2)2 M(Et-NC(Me)-N-Et)(OiPr)(NEtMe)2 , M(iPr-NC(NMe2) -N-iPr)(OiPr)(NMe2)2 , M(iPr-NC(NMe2)-N-iPr)(OiPr)(NEt2)2 , and M(iPr-NC(NMe2)-N-iPr)(OiPr) ) (NEtMe) 2. When M is Hf, the exemplary precursors include: Hf(iPr-N-C(Me)-N-iPr)(OiPr)(NMe2)2 ,

Hf(iPr-N-C(Me)-N-iPr)(OiPr)(NEt2)2 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)(NEt2)2 ,

Hf(iPr-N-C(Me)-N-iPr)(OiPr)(NEtMe)2 、Hf(iPr-N-C(Me)-N-iPr)(OiPr)(NEtMe)2 ,

Hf(Et-N-C(Me)-N-Et)(OiPr)(NMe2)2 、Hf(Et-N-C(Me)-N-Et)(OiPr)(NMe2)2 ,

Hf(Et-N-C(Me)-N-Et)(OiPr)(NEt2)2 、Hf(Et-N-C(Me)-N-Et)(OiPr)(NEt2)2 ,

Hf(Et-N-C(Me)-N-Et)(OiPr)(NEtMe)2 、Hf(Et-N-C(Me)-N-Et)(OiPr)(NEtMe)2 ,

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)(NMe2)2 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)(NMe2)2 ,

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEt2)2 , 及Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEt2)2 , and

Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEtMe)2。 當 M 為 Zr 時,該等例示性前驅物包括: Zr(iPr-N-C(Me)-N-iPr)(OiPr)(NMe2)2 、Hf(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEtMe)2. When M is Zr, the exemplary precursors include: Zr(iPr-N-C(Me)-N-iPr)(OiPr)(NMe2)2 ,

Zr(iPr-N-C(Me)-N-iPr)(OiPr)(NEt2)2 、Zr(iPr-N-C(Me)-N-iPr)(OiPr)(NEt2)2 ,

Zr(iPr-N-C(Me)-N-iPr)(OiPr)(NEtMe)Zr(iPr-N-C(Me)-N-iPr)(OiPr)(NEtMe)

Zr(Et-N-C(Me)-N-Et)(OiPr)(NMe2)2Zr(Et-N-C(Me)-N-Et)(OiPr)(NMe2)2

Zr(Et-N-C(Me)-N-Et)(OiPr)(NEt2)2Zr(Et-N-C(Me)-N-Et)(OiPr)(NEt2)2

Zr(Et-N-C(Me)-N-Et)(OiPr)(NEtMe)2 27 201241224Zr(Et-N-C(Me)-N-Et)(OiPr)(NEtMe)2 27 201241224

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)(NMe2)2 、Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)(NMe2)2 ,

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEt2)2 , 及Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEt2)2 , and

Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEtMe)2。 當在式II中v=l,x=l,y=l且z=0時,例示性前驅物 包 括 : M(iPr-N-(CH2)2-N-iPr)(OiPr)(NMe2) ' M(iPr-N_(CH2)2-N-iPr)(OiPr)(NEt2) 、 M(iPr-N-(CH2)2-N-iPr)(OiPr)(NEtMe) 、 M(Et-N-(CH2)2-N-Et)(OiPr)(NMe2) 、 M(Et-N-(CH2)2-N-Et)(OiPr)(NEt2) , 及 M(Et-N-(CH2)2-N-Et)(OiPr)(NEtMe)。當 M 為 Hf 時,該等 例示性前驅物包括:Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(NMe2)、 Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(NEt2) 、Zr(iPr-N-C(NMe2)-N-iPr)(OiPr)(NEtMe)2. When v = l, x = 1, y = 1, and z = 0 in Formula II, exemplary precursors include: M(iPr-N-(CH2)2-N-iPr)(OiPr)(NMe2) ' M(iPr-N_(CH2)2-N-iPr)(OiPr)(NEt2) , M(iPr-N-(CH2)2-N-iPr)(OiPr)(NEtMe) , M(Et-N-( CH2)2-N-Et)(OiPr)(NMe2) , M(Et-N-(CH2)2-N-Et)(OiPr)(NEt2) , and M(Et-N-(CH2)2-N -Et)(OiPr)(NEtMe). When M is Hf, the exemplary precursors include: Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(NMe2), Hf(iPr-N-(CH2)2-N-iPr )(OiPr)(NEt2) ,

Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(NEtMe) 'Hf(iPr-N-(CH2)2-N-iPr)(OiPr)(NEtMe) '

Hf(Et-N-(CH2)2-N-Et)(OiPr)(NMe2) 、Hf(Et-N-(CH2)2-N-Et)(OiPr)(NMe2),

Hf(Et-N-(CH2)2-N-Et)(OiPr)(NEt2) , 及Hf(Et-N-(CH2)2-N-Et)(OiPr)(NEt2), and

Hf(Et-N-(CH2)2-N-Et)(OiPr)(NEtMe)。當 M 為 Zr 時,該等 例示性前驅物包括:Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(NMe2)、 Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(NEt2) 'Hf(Et-N-(CH2)2-N-Et)(OiPr)(NEtMe). When M is Zr, the exemplary precursors include: Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(NMe2), Zr(iPr-N-(CH2)2-N-iPr )(OiPr)(NEt2) '

Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(NEtMe) 、Zr(iPr-N-(CH2)2-N-iPr)(OiPr)(NEtMe),

Zr(Et-N-(CH2)2-N-Et)(OiPr)(NMe2) 、Zr(Et-N-(CH2)2-N-Et)(OiPr)(NMe2),

Zr(Et-N-(CH2)2-N-Et)(OiPr)(NEt2) , 及Zr(Et-N-(CH2)2-N-Et)(OiPr)(NEt2), and

Zr(Et-N-(CH2)2-N-Et)(OiPr)(NEtMe)。 當在式I中u=l,x=l,y=0且z=2時,例示性前驅物 包 括 : M(iPr-N-C(Me)-N-iPr)(OiPr) (02CMe)2 及 28 201241224 M(Et-N-C(Me)-N-Et)(0iPr)(02CMe)2。當 Μ 為 Hf 時,該等 例示性前驅物包括:Hf(iPr-N-C(Me)-N-iPr)(OiPr) (02CMe)2 及 Hf(Et-N-C(Me)-N-Et)(0iPr)(02CMe)2。當 Μ 為 Zr 時,該 等例示性前驅物包括:Zr(iPr-N-C(Me)-N-iPr;K〇iPr;) (02CMe)2 及 Zr(Et-N-C(Me)-N-Et)(0iPr)(02CMe)2。 當在式I或式II中之任一者中u、v、y=0,χ=2且z=2 時,例示性前驅物包括M(0iPr)2(02CMe)2,或當Μ為Hf 時,例示性前驅物包括Hf(OiPr)2(〇2CMe)2,且當Μ為Zr 時,例示性前驅物包括Zr(OiPr)2(〇2CMe)2 » 當在式I或式II中之任一者中u、v、y=0,χ=3且z=l 時’例示性前驅物包括M(OiPr)3(〇2CMe),或當μ為Hf時, 例示性前驅物包括Hf(OiPr)3(〇2CMe),且當Μ為Zr時,例 示性前驅物包括Zr(OiPr)3(〇2C]VIe)。 可藉由在氮氣氛圍下組合Η(Ι^_Ν-(:(Ι13)-Ν-Ι12)之烴溶 液與铪或锆化合物(諸如,Hf(〇R4)3(NR5R6)、 Hf(OR4)2(NR5R6)2、Zr(OR4)3(NR5R6),或 Zr(〇R4)2(NR5R6)2) 之淨溶液或烴溶液來合成該等所揭示之前驅物,混合燒瓶 之出口連接至油起泡器 例示性烴溶液包括戊烷。隔夜在Zr(Et-N-(CH2)2-N-Et)(OiPr)(NEtMe). When u = l, x = 1, y = 0, and z = 2 in Formula I, exemplary precursors include: M(iPr-NC(Me)-N-iPr)(OiPr) (02CMe)2 and 28 201241224 M(Et-NC(Me)-N-Et)(0iPr)(02CMe)2. When Μ is Hf, the exemplary precursors include: Hf(iPr-NC(Me)-N-iPr)(OiPr) (02CMe)2 and Hf(Et-NC(Me)-N-Et) (0iPr) ) (02CMe) 2. When Μ is Zr, the exemplary precursors include: Zr(iPr-NC(Me)-N-iPr; K〇iPr;) (02CMe)2 and Zr(Et-NC(Me)-N-Et) (0iPr)(02CMe)2. When u, v, y = 0, χ = 2, and z = 2 in either of Formula I or Formula II, the exemplary precursor includes M(0iPr)2(02CMe)2, or when Μ is Hf When the exemplary precursor includes Hf(OiPr)2(〇2CMe)2, and when Μ is Zr, the exemplary precursor includes Zr(OiPr)2(〇2CMe)2 » when in Formula I or Formula II In any of u, v, y = 0, χ = 3 and z = 1, 'exemplary precursors include M(OiPr) 3 (〇2CMe), or when μ is Hf, the exemplary precursors include Hf ( OiPr)3 (〇2CMe), and when Μ is Zr, the exemplary precursor includes Zr(OiPr)3(〇2C]VIe). A hydrocarbon solution of ruthenium (Ι^_Ν-(:(Ι13)-Ν-Ι12) can be combined with a ruthenium or zirconium compound (such as Hf(〇R4)3(NR5R6), Hf(OR4)2 by a nitrogen atmosphere. (NR5R6)2, Zr(OR4)3(NR5R6), or a pure solution or hydrocarbon solution of Zr(〇R4)2(NR5R6)2) to synthesize the precursors disclosed, and the outlet of the mixing flask is connected to the oil. The exemplary hydrocarbon solution of the bubbler includes pentane.

-’^ % ·刀-別楮由蒸餾或昇華執行所得液體-'^ % · Knife - Do not perform the liquid obtained by distillation or sublimation

29 201241224 前驅物分別用於沉積含姶及含锆膜之使用。該等所揭示之 方法可用於半導體、光伏打裝置、LCD-TFT或平板型裝置 之製造中。該方法包括:提供基板;提供包括該等所揭示 之含铪或含鍅前驅物中之至少一者之蒸汽;及使該蒸汽與 該基板接觸(且典型地將該蒸汽引向該基板)以在該基板 之至少一表面上形成含給或含錯層。 s亥等所揭示之方法亦提供用於使用氣相沉積製程在基 板上形成含雙金屬層。該等所揭示之方法可用於半導體、 光伏打裝置、LCD-TFT或平板型裝置之製造中,該方法包 括:提供基板;提供包括該等所揭示之含銓或含锆前驅物 中之至少一者之蒸汽;及使該蒸汽與該基板接觸(且典型 地將該蒸汽引向該基板)以在該基板之至少一表面上形成 含雙金屬層。亦可提供氧源,諸如〇3、〇2、h2〇及N〇,較 佳為h2o。 該等所揭示之含铪及含锆前驅物可用以使用熟習此項 技術者已知之任何沉積方法沉積含姶及含鍅膜。合適沉積 方法之實例包括(不限制)習知化學氣相沉積(CVD )、低 壓化學氣相沉積(LPCVD)、原子層沉積(ALD)、脈衝化 學氣相沉積(P-CVD)、電漿增強原子層沉積(pE_ALD), 或其組合。較佳地,該沉積方法為ALD或pE_ALD。 將忒含铪或含锆前驅物之蒸汽引入至含有至少一基板 之反應腔至中。在合適條件下保持該反應腔室内之溫度及 壓力及該基板之溫度,以使得該含铪或含鍅前驅物與該基 板之間的接觸導致在該基板之至少一表面上形成含Hf或含 30 20124122429 201241224 Precursors are used for the deposition of tantalum-containing and zirconium-containing films, respectively. The methods disclosed herein can be used in the fabrication of semiconductors, photovoltaic devices, LCD-TFT or flat panel devices. The method includes: providing a substrate; providing a vapor comprising at least one of the disclosed germanium- or germanium-containing precursors; and contacting the vapor with the substrate (and typically directing the vapor to the substrate) A donor layer or a miscible layer is formed on at least one surface of the substrate. The method disclosed by shai et al. also provides for forming a bimetallic-containing layer on a substrate using a vapor deposition process. The methods disclosed herein can be used in the manufacture of semiconductors, photovoltaic devices, LCD-TFT or flat-type devices, the method comprising: providing a substrate; providing at least one of the disclosed cerium- or zirconium-containing precursors The vapor of the person; and contacting the vapor with the substrate (and typically directing the vapor to the substrate) to form a bimetallic-containing layer on at least one surface of the substrate. Oxygen sources such as 〇3, 〇2, h2〇 and N〇 may also be provided, preferably h2o. The disclosed cerium-containing and zirconium-containing precursors can be used to deposit cerium-containing and cerium-containing films using any deposition method known to those skilled in the art. Examples of suitable deposition methods include, without limitation, conventional chemical vapor deposition (CVD), low pressure chemical vapor deposition (LPCVD), atomic layer deposition (ALD), pulsed chemical vapor deposition (P-CVD), plasma enhanced Atomic layer deposition (pE_ALD), or a combination thereof. Preferably, the deposition method is ALD or pE_ALD. The ruthenium- or zirconium-containing precursor vapor is introduced into the reaction chamber containing at least one substrate. Maintaining the temperature and pressure within the reaction chamber and the temperature of the substrate under suitable conditions such that contact between the ruthenium- or ruthenium-containing precursor and the substrate results in the formation of Hf-containing or inclusions on at least one surface of the substrate 30 201241224

Zr層。亦可使用反應物來幫助形成該含Hf或含Zr層。 該反應腔室可為裝置之進行沉積方法之任何外殼或腔 至’諸如(不限制)平行板型反應器、冷壁型反應器、熱 壁型反應器、單晶圓反應器、多晶圓反應器,或其他此等 類型之’/儿積系統。所有此等例示性反應腔室能夠用作Ald 反應腔室。該反應腔室可維持在自約〇.5毫托(〇 〇7pa)至 約20托( 2700 Pa)之壓力範圍内。另外,該反應腔室内之 β亥狐度可在約200 C至約600°C之範圍内。一般熟習此項技 術者將認識到’可經由用以達成所要結果之純實驗使該溫 度最佳化。 可藉由控制基板固持器之溫度或控制反應器壁之溫度 來控制該反應腔室之該溫度。用以加熱該基板之裝置為此 項技術中已知的。將該反應器壁加熱至足夠溫度以在足夠 生長速率下獲得該所要膜且該所要膜具有所要物理狀態及 組成物。該反應器壁可被加熱至之一非限制性例示性溫度 範圍包括自約200 C至約600°C。當利用電聚沉積製程時, 沉積溫度可在約200。(:至約55CTC之範圍内。或者,當執行 熱製程時,沉積溫度可在約400°c至約6〇〇〇c之範圍内。 或者’可將該基板加熱至足夠溫度以在足夠生長速率 下獲得該所要含铪或含鍅膜且該所要含铪或含錯膜具有所 要物理狀態及組成物。該基板可被加熱至之一非限制性例 示性溫度範圍包括自1 5〇。(:至6001。較佳地,該基板之該 溫度保持小於或等於45(TC。 該含铪或含锆膜將沉積於上面的基板之類型將取決於 31 201241224 思欲之最終用途而變化。在一些具體實例中,該基板可選 自以下各者:用作MIM、DRAM或FeRam技術中之介電材 料的氧化物(例如,基於職之材料、基於Ti〇2之材料、 基於Zr〇2之材料、基於稀土元素氧化物之材料、基於三元 氧化物之材料,冑#),或用作銅與低k層之間的氧障壁的 基於氮化物之膜(例如’ TaN)。其他基板可用於半導體、 光伏打裝置、LCD-TFT s戈平板裝置之製造中。此等基板之 實例包括(但不限於)固體基板,諸如含金屬氮化物基板 (例如,TaN、TiN ' WN、TaCN、TiCN、TaSiN,及 TiSiN ); 絕緣體(例如,Si02、Si3N4、SiON、Hf02、Ta2〇5、Zr〇2、 Ti〇2、Al2〇3’及鈦酸勰鋇);或其他基板,包括此等材料之 任何數目個組合。該所利用之實際基板亦可取決於該所利 用之特定前驅物具體實例。但在許多例子中,該所利用之 較佳基板將選自以下各者:TiN、SRO、Ru及Si型基板。 在將s亥含給或含錯.前驅物引入至該反應腔室中之前, 可將該含铪或含锆前驅物以液態饋入至汽化器,在該汽化 器中’該含铪或含鍅前驅物汽化。在該含铪或含鍅前驅物 化之前’可視情況將該含給或含錯前驅物與以下各者混 合:一或多個溶劑、一或多個金屬源,及一或多個溶劑與 —或多個金屬源之混合物。該等溶劑可選自由以下各者組 成之群:曱本、乙本、一曱苯 '均三曱苯、癸烧、十二烧' 辛烷、己烷、戊烷,或其他者。所得濃度可在約〇.〇5 M至 約2 Μ之範圍内。該金屬源可包括現在已知或稍後開發之 任何含金屬前驅物。 32 201241224 或者,可藉由將③載氣體裁入至含有該含給或含錯前 驅物之容器中或藉由使該運載氣體起泡至該含铪或含錯前 驅物中來使該含給或含錯前驅物汽化。接著將該運載氣體 及該含給或含錯前驅物以蒸汽形式引人至該反應腔室中。 該運载氣體可包括(但不限於)Ar、He、ν2,及其混。 可視情況在該容器中將該含铪或含鍅前驅物與一或多個溶 劑、含金屬前驅物或其混合物混合。必要時,可將該容器 加熱至溫度’該溫度准許該含給或含錘前驅物處於其液相 且具有足夠蒸汽壓。該容器可維持在處於(例如)約〇。。至 約15(TC之範圍内的溫度。熟習此項技術者認識到,可以已 知方式調整該容器之該溫度,以控制含铪或含鍅前驅物汽 化之量。 义除在引入至該反應腔室中之前可選地將該含給或含結 前驅物與溶劑、含金屬前驅物及穩定骸合之外,亦可將 該含給或含錯前驅物與該反應腔室内部之反應物混合。例 不性反應物包括(不限制)含金屬前驅物,諸如含鋁前驅 物(諸如’TMA)或含砂前驅物(諸如,雙(二乙胺基)石夕烧)。 可將少量此等或其他含金屬前驅物併入至該所得膜中,作 為換,劑’或作為該所得膜中之第二或第三金屬,諸如PZT。 田〇亥所要含給或含錯膜亦含有氧(諸如(且不限制) =〇).時’該等反應物可包括選自(但不限於)以下各者之 一 ' 2 〇3 H2〇、^2〇2、乙酸、福馬林、仲甲醛,及其 組合較佳地,#執行ALD製程時,該反應物為H2〇。 可藉由電漿來處理該反應物以便將該反應物分解成其 33 201241224 自由基形式。該電漿可產生或存在於自身之反應腔室内。 或者’可大體上在位置處將該電漿自該反應腔室中释除, 例如,在位於遠端之電漿系統中。熟習此項技術者將認識 到適合於此電漿處理之方法及設備。 舉例而言,可將該反應物引入至直接電漿反應器中(該 直接電漿反應器在該反應腔室中產生電漿),以在該反應腔 至中產生該經電讓處理之反應物。例示性直接電衆反應器 包括由 Trion Technologies 生產之 Titan™ PECVD 系統。可 在電漿處理之前將該反應物引入及固持於該反應腔室中。 或者,該電漿處理可與反應物之該引入同時地發生。原位 電漿典型地為13.56 MHz RF電容耦合電漿,其產生於簇射 頭與δ亥基板固持器之間。該基板或簇射頭可取決於是否發 生正離子衝擊而為供電電極。原位電漿產生器中之典型外 加功率為約1〇〇 w至約1〇〇〇 w。使用原位電漿達成的該反 應物之解離典型地小於對於相同功率輸入使用遠端電漿源 達成的该反應物之解離,且因此反應物解離不如遠端電漿 系統中之反應物解離有效率,此情形可有益於在基板上沉 積容易受電漿損壞之含金屬氮化物臈。 或者,可在該反應腔室外部產生該經電漿處理之反應 物。在載入至該反應腔室中之前,可使用MKS Instruments 之astron®i反應性氣體產生器來處理該反應物。在2 45 GHz、7 kW電漿功率及在約3托至約1 〇托之範圍内的壓力 下操作,可將反應物〇3分解成三個〇·自由基。較佳地,可 用在約1 kW至約10 kW之範圍内、更佳在約2 5 kw至約 34 201241224 7.5 kW之範圍内的功率產生該遠端電襞。 §3亥所要含給或含銘·膜亦含有另一金屬(諸如 V立不 限制)Ta、Hf、Zr、Nb、Mg、Al、Sr、Y、Ba、Γη * ' As 'Zr layer. Reactants can also be used to help form the Hf-containing or Zr-containing layer. The reaction chamber can be any housing or chamber for the deposition method of the device to 'such as (without limitation) parallel plate type reactor, cold wall type reactor, hot wall type reactor, single wafer reactor, multi wafer Reactors, or other such types of '/product systems. All such exemplary reaction chambers can be used as an Ald reaction chamber. The reaction chamber can be maintained at a pressure ranging from about 毫5 mTorr (〇7 Pa) to about 20 Torr (2700 Pa). Additionally, the beta octave in the reaction chamber can range from about 200 C to about 600 °C. Those of ordinary skill in the art will recognize that the temperature can be optimized by a pure experiment to achieve the desired result. The temperature of the reaction chamber can be controlled by controlling the temperature of the substrate holder or controlling the temperature of the reactor wall. Apparatus for heating the substrate is known in the art. The reactor wall is heated to a temperature sufficient to obtain the desired film at a sufficient growth rate and the desired film has the desired physical state and composition. The reactor wall can be heated to one of a non-limiting exemplary temperature range including from about 200 C to about 600 °C. When utilizing an electropolymer deposition process, the deposition temperature can be about 200. (: to a range of about 55 CTC. Or, when performing a thermal process, the deposition temperature may be in the range of about 400 ° C to about 6 ° C. Or 'the substrate can be heated to a sufficient temperature to grow enough The desired ruthenium or ruthenium containing film is obtained at a rate and the desired ruthenium or ruthenium containing film has the desired physical state and composition. The substrate can be heated to one of the non-limiting exemplary temperature ranges including from 15 〇. Preferably, the temperature of the substrate is maintained to be less than or equal to 45 (TC. The type of substrate on which the cerium- or zirconium-containing film will be deposited will vary depending on the end use of 31 201241224. In some embodiments, the substrate can be selected from the group consisting of oxides used as dielectric materials in MIM, DRAM, or FeRam technology (eg, work-based materials, Ti〇2-based materials, based on Zr〇2) Materials, materials based on rare earth oxides, materials based on ternary oxides, 胄#), or nitride-based films (eg 'TaN) used as oxygen barriers between copper and low-k layers. Other substrates are available For semiconductors, photovoltaic devices, LC In the manufacture of D-TFT s-go plate devices, examples of such substrates include, but are not limited to, solid substrates, such as metal-containing nitride substrates (eg, TaN, TiN 'WN, TaCN, TiCN, TaSiN, and TiSiN); Insulators (eg, SiO 2 , Si 3 N 4 , SiON, HfO 2 , Ta 2 〇 5, Zr 〇 2, Ti 〇 2, Al 2 〇 3 ′ and barium titanate); or other substrates, including any number of combinations of such materials. The actual substrate utilized may also depend on the particular precursor embodiment utilized. However, in many instances, the preferred substrate utilized will be selected from the group consisting of TiN, SRO, Ru, and Si-type substrates. The cerium- or zirconium-containing precursor may be fed in a liquid state to a vaporizer in which the cerium-containing or cerium-containing precursor is introduced before or after the precursor is introduced into the reaction chamber. Vaporization. Before the ruthenium or ruthenium containing precursor is oxidized, the fused or misproducible precursor may be optionally mixed with one or more solvents, one or more metal sources, and one or more solvents and - or a mixture of multiple metal sources. These solvents can be selected from the following The group consisting of: 曱本,乙本,一曱 benzene 'all triterpene benzene, 癸 、, 十二烧 ' octane, hexane, pentane, or others. The concentration can be obtained in about 〇.〇5 M to a range of about 2 。. The metal source may include any metal-containing precursor now known or later developed. 32 201241224 Alternatively, it may be cut into the containing precursor containing or containing the wrong precursor by The contained or misproducible precursor is vaporized in a vessel or by bubbling the carrier gas to the ruthenium containing or misproducing precursor. The carrier gas and the containing or containing precursor are then The vapor form is introduced into the reaction chamber. The carrier gas can include, but is not limited to, Ar, He, ν2, and mixtures thereof. The ruthenium containing or ruthenium containing precursor may optionally be combined with one or more solvents, metal containing precursors or mixtures thereof in the vessel. If necessary, the vessel can be heated to a temperature which permits the containing or containing hammer precursor to be in its liquid phase and has a sufficient vapor pressure. The container can be maintained at, for example, about 〇. . To a temperature in the range of about 15 (TC), those skilled in the art recognize that the temperature of the vessel can be adjusted in a known manner to control the amount of vaporization of the ruthenium containing or ruthenium containing precursor. The chamber may optionally be combined with a solvent, a metal-containing precursor, and a stable precursor prior to the chamber, and the reactant containing or containing the precursor may be reacted with the interior of the reaction chamber. Mixing. Examples of inactive reactants include, without limitation, metal-containing precursors, such as aluminum-containing precursors (such as 'TMA) or sand-containing precursors (such as bis(diethylamino) sulphur). These or other metal-containing precursors are incorporated into the resulting film as a replacement agent' or as a second or third metal in the resulting film, such as PZT. The field containing or containing the wrong film also contains Oxygen (such as (and without limitation) = 〇). The reactants may include one selected from the group consisting of: 2 〇3 H2〇, ^2〇2, acetic acid, formalin, secondary Formaldehyde, and combinations thereof, preferably, when the ALD process is performed, the reactant is H2〇. Slurry to treat the reactants to decompose the reactants into their 33 201241224 free radical form. The plasma can be produced or present in its own reaction chamber. Or 'the plasma can be substantially from the reaction chamber at the location Discharge in the chamber, for example, in a remotely located plasma system. Those skilled in the art will recognize methods and apparatus suitable for such plasma processing. For example, the reactants can be introduced into direct plasma In the reactor (the direct plasma reactor produces a plasma in the reaction chamber) to produce the electrically treated reactant in the reaction chamber. The exemplary direct electricity reactor includes a production by Trion Technologies. a TitanTM PECVD system that can be introduced and held in the reaction chamber prior to plasma treatment. Alternatively, the plasma treatment can occur simultaneously with the introduction of the reactants. In situ plasma is typically A 13.56 MHz RF capacitively coupled plasma is produced between the showerhead and the δH substrate holder. The substrate or showerhead can be a supply electrode depending on whether a positive ion impact occurs. Typical applied power in the device is from about 1 〇〇w to about 1 〇〇〇w. Dissociation of the reactants achieved using in-situ plasma is typically less than that achieved with a remote plasma source for the same power input. The dissociation, and therefore the dissociation of the reactants, is less efficient than the dissociation of the reactants in the remote plasma system, which may be beneficial for depositing a metal-containing nitride crucible that is susceptible to damage by the plasma on the substrate. Alternatively, in the reaction chamber The plasma treated reactant is externally generated. The reactant can be treated with MKS Instruments' antron® i reactive gas generator prior to loading into the reaction chamber. Plasma at 2 45 GHz, 7 kW The power and operation at a pressure in the range of from about 3 Torr to about 1 Torr can decompose the reactant 〇3 into three 〇· radicals. Preferably, the remote power is generated in a range from about 1 kW to about 10 kW, more preferably from about 25 kW to about 34 201241224 7.5 kW. §3Hai must contain or contain a film. The film also contains another metal (such as V is not limited) Ta, Hf, Zr, Nb, Mg, Al, Sr, Y, Ba, Γη * ' As '

Sb、Bi、Sn、Pb、Co、鑭系元素(諸如,Eu)或其組合時, 該等反應物可包括選自(但不限於)以下各者之含金屬1 驅物:金屬烷,諸如Ln(RCp)3或Co(RCp)2 ;金屬烷氧,諸 如Ti(Cp)(OMe)3 ;及其任何組合。 將該含金屬前驅物之蒸汽引入至反應腔室中。在合適 條件下保持該反應腔室内之溫度及壓力及該基板之溫度, 以使得該含金屬前驅物與該基板之間的接觸導致在該基板 之至少一表面上形成含金屬層。亦可使用反應物來幫助形 成該含金屬層。 一般熟習此項技術者將認識到,可在該等所揭示之沉 積製程中使用額外反應物。 可同時地(化學氣相沉積)、順序地(原子層沉積)或 以其他組合將該含铪或含錯前驅物及一或多㈣反應物引入 至該反應腔室中。舉例而言’可在—個脈衝中引人該含給 或含錯前驅物且可在單獨脈衝中—起引人兩個額外金屬源 [經修改之原子層沉積]。或者,在引入該含給或含錯前驅物 之前,該反應腔室可能已經含有該反應物。可使該反― 通過定域於該反應腔室遠端之電漿系统,且將該反應物分 成自由s或者可在藉由脈衝引入其他金屬源(脈衝 化學氣相沉積)的同時,連續地將該含給或含錯前驅物引 至《亥反應&室°在每—實施例中,脈衝可繼之以淨化或 35 201241224 抽空步驟以移除所引入之過量組份。在每-實施例中’該 脈衝可持續時間週期,該時間週期在约0.01 s至約10 s之 範圍内’或者在約0.3 s至約3 8之範圍内,或者在約0.5 S 至約2 s之範圍内。 在非限制性例示性原子層沉積型製程中,將含铪或 含錯前驅物之蒸汽相引人至該反應腔室中,在該反應腔室 I ’該含铪或含錯前驅物之蒸汽相與合適基板接觸。可接 著藉由淨化及/或抽空該反應腔室將過量含銓或含鍅前驅物 自該反應腔室中移除。將氧源引入至該反應腔室中,在該 反應腔室中,該氧源與該所吸收之含铪或含鍅前驅物以自 限制方式起反應'藉由淨化及/或抽空該反應腔室將任何過 置氧源自該反應腔室中移除。若該所要膜為氧化铪或氧化 锆膜,則此兩步驟製程可提供所要膜厚度,或可重複此兩 步驟製程,直至獲得具有必要厚度之膜為止。 或者,若該所要膜為鈐或錯金屬氧化物膜,則可在該 上述兩步驟製程之後,將含金屬前驅物之第二蒸汽引入至 該反應腔室中。將基於正沉積之該铪金屬氧化物或錯金屬 氧化物膜之性質而選擇該含金屬前驅物。在引入至該反應 腔至中之後,使δ亥含金屬前驅物與該基板接觸。藉由淨化 及/或抽空該反應腔室將任何過量含金屬前驅物自該反應腔 至中移除。再··人,可將氧源引入至該反應腔室中以與該含 金屬前驅物反應。藉由淨化及/或抽空該反應腔室將過量氧 源自S亥反應腔至中移除。若已達成所要膜厚度,則可終止 S亥製程。然而,若需要較厚膜,則可重複該整個四步驟製 36 201241224 程。藉由交替供應該含給或含錯前驅物、該含金屬前驅物 及δ亥氧源’可、/儿積具有所要組成物及厚度之膜。 另外’藉由使脈衝之數目變化,可獲得具有所要化學 計算量Hf:金屬或Zr:金屬比之膜。舉例而言,可藉由具有 該含锆前驅物之一個脈衝、含鈦前驅物之一個脈衝及含鉛 前驅物之兩個脈衝而獲得ΡΖΤ膜(Pb[ZrxTii χ]〇3,其中 0<χ<1),其中每一脈衝繼之以該氧源之脈衝。然而,一般 熟習此項技術者將認識到,獲得該所要膜所需之脈衝之數 目可能不相同於該所得膜之該化學計算量比。 由上文所論述之該等製程產生的該等含铪或含鍅膜可 包括ΡΖΤ。一般熟習此項技術者將認識到,藉由慎重地選擇 適當含姶或含鍅前驅物及反應物,可獲得所要膜組成物。 .實施例 提供以下非限制性實施例以進一步說明本發明之具體 實例。然而,該等實施例並不意欲為全部包括性的且並不 意欲限制本文中所描述的本發明之範嘴。 預言性實施例1When Sb, Bi, Sn, Pb, Co, a lanthanide element (such as Eu), or a combination thereof, the reactants may include a metal-containing 1 drive selected from, but not limited to, the following: a metal alkane, such as Ln(RCp)3 or Co(RCp)2; a metal alkane, such as Ti(Cp)(OMe)3; and any combination thereof. The vapor containing the metal precursor is introduced into the reaction chamber. The temperature and pressure within the reaction chamber and the temperature of the substrate are maintained under suitable conditions such that contact between the metal-containing precursor and the substrate results in the formation of a metal-containing layer on at least one surface of the substrate. Reactants can also be used to help form the metal containing layer. Those of ordinary skill in the art will recognize that additional reactants may be utilized in such disclosed deposition processes. The ruthenium containing or erroneous precursor and one or more (iv) reactants can be introduced into the reaction chamber simultaneously (chemical vapor deposition), sequentially (atomic layer deposition) or in other combinations. For example, the containing or containing precursors may be introduced in one pulse and may be introduced in separate pulses to introduce two additional metal sources [modified atomic layer deposition]. Alternatively, the reaction chamber may already contain the reactants prior to introduction of the containing or containing precursor. The reverse can be passed through a plasma system localized to the distal end of the reaction chamber, and the reactants can be separated into free s or continuously introduced by pulse into other metal sources (pulsed chemical vapor deposition). The containing or misproducing precursor is directed to the "Reaction" chamber. In each of the examples, the pulse may be followed by a purge or 35 201241224 evacuation step to remove the excess component introduced. In each embodiment, the pulse may last for a period of time ranging from about 0.01 s to about 10 s or from about 0.3 s to about 38, or from about 0.5 S to about 2 Within the scope of s. In a non-limiting exemplary atomic layer deposition process, a vapor phase containing a ruthenium- or precursor-containing precursor is introduced into the reaction chamber, and the vapor containing the ruthenium or the precursor is contained in the reaction chamber I The phase is in contact with a suitable substrate. Excess ruthenium or ruthenium containing precursor can then be removed from the reaction chamber by purging and/or evacuating the reaction chamber. Introducing an oxygen source into the reaction chamber in which the oxygen source reacts with the absorbed ruthenium or ruthenium containing precursor in a self-limiting manner by purging and/or evacuating the reaction chamber The chamber removes any excess oxygen from the reaction chamber. If the desired film is a yttria or zirconia film, the two-step process can provide the desired film thickness, or the two-step process can be repeated until a film having the necessary thickness is obtained. Alternatively, if the desired film is a germanium or a metal oxide film, a second vapor containing a metal precursor may be introduced into the reaction chamber after the two-step process. The metal-containing precursor will be selected based on the nature of the ruthenium metal oxide or metal oxide film being deposited. After introduction into the reaction chamber, the ?-metal precursor is brought into contact with the substrate. Any excess metal-containing precursor is removed from the reaction chamber by purging and/or evacuating the reaction chamber. Further, an oxygen source can be introduced into the reaction chamber to react with the metal-containing precursor. Excess oxygen is removed from the S-reaction chamber by removing it by purging and/or evacuating the reaction chamber. If the desired film thickness has been achieved, the S-Hail process can be terminated. However, if a thicker film is required, the entire four-step process can be repeated. The film having the desired composition and thickness can be alternately supplied by alternately supplying the supplied or contained precursor, the metal-containing precursor, and the ?-oxygen source. Further, by changing the number of pulses, a film having a desired stoichiometric amount of Hf: metal or Zr: metal ratio can be obtained. For example, a ruthenium film (Pb[ZrxTii χ] 〇3, where 0 0<lt<>> can be obtained by having one pulse of the zirconium containing precursor, one pulse of the titanium-containing precursor, and two pulses of the lead-containing precursor ; 1), wherein each pulse is followed by a pulse of the oxygen source. However, those of ordinary skill in the art will recognize that the number of pulses required to obtain the desired film may not be the same as the stoichiometric ratio of the resulting film. The ruthenium containing or ruthenium containing films produced by the processes discussed above may include ruthenium. Those of ordinary skill in the art will recognize that the desired film composition can be obtained by careful selection of the appropriate ruthenium or ruthenium containing precursor and reactants. EXAMPLES The following non-limiting examples are provided to further illustrate specific examples of the invention. However, the embodiments are not intended to be all inclusive and are not intended to limit the scope of the invention described herein. Prophetic Example 1

Hf(N -amd)(〇ipr)3 或 Zr(NiPr_amd)(〇ipr)3:將戊烷 溶液冷卻至-30°C歷時1小時。將Hf(〇ipr)3(NMe2)或 Zr(OiPr)3(NMe2)添加至冷卻之戊烷溶液。在氮氣氛圍下在 至溫下攪拌混合物》將NiPr_amd_H戊烷溶液緩慢地添加至 上述混.合物。將燒瓶之出口連接至油起泡器,又將該油起 泡器連接至酸洗滌器。隔夜在室溫下攪拌所得溶液。在真 空下將溶劑及揮發物自反應混合物中移除,從而產生目標 37 201241224 分子(Hf(NiPr-amd)(OiPr)3 或 Zr(NiPr-amd)(OiPr)3)。 預言性實施例2Hf(N -amd)(〇ipr)3 or Zr(NiPr_amd)(〇ipr)3: The pentane solution was cooled to -30 ° C for 1 hour. Hf(〇ipr)3(NMe2) or Zr(OiPr)3(NMe2) was added to the cooled pentane solution. The mixture was stirred at a temperature under a nitrogen atmosphere. The NiPr_amd_H pentane solution was slowly added to the above mixture. The outlet of the flask was connected to an oil bubbler and the oil bubbler was connected to the acid scrubber. The resulting solution was stirred at room temperature overnight. The solvent and volatiles are removed from the reaction mixture under vacuum to yield the target 37 201241224 molecule (Hf(NiPr-amd)(OiPr)3 or Zr(NiPr-amd)(OiPr)3). Prophetic Example 2

Hf(NiPl"-amd)2(OiPr)2 或 Zr(NlPr-amd)2(〇iPr)2 :將淨Hf(NiPl"-amd)2(OiPr)2 or Zr(NlPr-amd)2(〇iPr)2 : will be net

Hf(OiPr)2(NMe2)2 或淨 Zr(OiPr)2(NMe2)2 添加至在氮氣氛圍 下在室溫下攪拌的含有NlPr-amd-H之戊炫溶液,將燒瓶之 出口連接至油起泡器。隔夜在室溫下攪拌所得溶液。在真 空下將溶劑及揮發物自反應混合物中移除,從而產生目標 分子(Hf(NlPr-amd)2(OiPr)2 或 Zr(NlPr-amd)2(OiPr)2)。 預言性實施例3Hf(OiPr)2(NMe2)2 or neat Zr(OiPr)2(NMe2)2 is added to a solution containing NlPr-amd-H, which is stirred at room temperature under a nitrogen atmosphere, and the outlet of the flask is connected to the oil. Bubbler. The resulting solution was stirred at room temperature overnight. The solvent and volatiles are removed from the reaction mixture under vacuum to produce the target molecule (Hf(NlPr-amd)2(OiPr)2 or Zr(NlPr-amd)2(OiPr)2). Prophetic Example 3

Hf(NlPr-fmd)2(OiPr)2 或 Zr(NiPr-fmd)2(〇iPr)2 :將淨Hf(NlPr-fmd)2(OiPr)2 or Zr(NiPr-fmd)2(〇iPr)2 : will be net

Hf(OiPr)2(NMe2)2 或淨 Zr(OiPr)2(NMe2)2 添加至在氮氣氛圍 下在室溫下攪拌的含有NiPr-fmd-H之戊烷溶液,將燒瓶之 出口連接至油起泡器。隔夜在室溫下攪拌所得溶液。在真 空下將溶劑及揮發物自反應混合物中移除,從而產生目標 分子(Hf(NiPr-fmd)2(OiPr)2 或 Zr(NiPr-fmd)2(OiPr)2)。 預言性實施例4Hf(OiPr)2(NMe2)2 or neat Zr(OiPr)2(NMe2)2 is added to a solution containing NiPr-fmd-H in pentane stirred at room temperature under a nitrogen atmosphere, and the outlet of the flask is connected to the oil. Bubbler. The resulting solution was stirred at room temperature overnight. The solvent and volatiles are removed from the reaction mixture under vacuum to produce the target molecule (Hf(NiPr-fmd)2(OiPr)2 or Zr(NiPr-fmd)2(OiPr)2). Prophetic Example 4

Hf(NiPr-gmd)2(OiPr)2 或 Zr(NiPr-gmd)2(OiPr)2 :將淨Hf(NiPr-gmd)2(OiPr)2 or Zr(NiPr-gmd)2(OiPr)2 : will be net

Hf(〇iPr)2(NMe2)2 或淨 Zr(OiPr)2(NMe2)2 添加至在氮氣氛圍 下在室溫下攪拌的含有iPr-N=C=N-iPr之戊烷溶液,將燒瓶 之出口連接至油起泡器。隔夜在室溫下攪拌所得溶液。在 真空下將溶劑及揮發物自反應混合物中移除,從而產生目 標分子(Hf(NlPr-gmd)2(OiPr)2 或 Zr(NlPr-gmd)2(OiPr)2)。 預言性實施例5Hf(〇iPr)2(NMe2)2 or net Zr(OiPr)2(NMe2)2 was added to a solution containing iPr-N=C=N-iPr in pentane stirred at room temperature under a nitrogen atmosphere. The outlet is connected to the oil bubbler. The resulting solution was stirred at room temperature overnight. The solvent and volatiles are removed from the reaction mixture under vacuum to yield the target molecule (Hf(NlPr-gmd)2(OiPr)2 or Zr(NlPr-gmd)2(OiPr)2). Prophetic Example 5

Hf(NiPr-amd)(OiPr)2(NMe2) 或 38 201241224Hf(NiPr-amd)(OiPr)2(NMe2) or 38 201241224

Zr(NlPl"-amd)(OiPr)2(NMe2):將 NiPr-amd-H 戊烷溶液緩慢 地逐滴添加至在氮氣氛圍下在室溫下撥拌的含有 Hf(OiPr)2(NMe2)2 或 Zr(OiPr)2(NMe2)2 之戊烷溶液。將燒瓶 之出口連接至油起泡器,又將該油起泡器連接至酸洗務 器。隔仪在室溫下搜拌所得溶液。在真空下將溶劑及揮發 物自反應混合物中移除,從而產生目標分子 (Hf(NlPr-amd)(OiPr)2(NMe2)或 Zr(NiPr-amd)(OiPr)2(NMe2))。 預言性實施例6Zr(NlPl"-amd)(OiPr)2(NMe2): Slowly add NiPr-amd-H pentane solution to Hf(OiPr)2(NMe2) mixed at room temperature under nitrogen atmosphere 2 or a solution of Zr(OiPr)2(NMe2)2 in pentane. The outlet of the flask was connected to an oil bubbler and the oil bubbler was connected to the pickler. The resulting solution was mixed at room temperature. The solvent and volatiles are removed from the reaction mixture under vacuum to yield the target molecule (Hf(NlPr-amd)(OiPr)2(NMe2) or Zr(NiPr-amd)(OiPr)2(NMe2)). Prophetic Example 6

Hf(Et-N-(CH2)2-N-Et)(OiPr)2 或Hf(Et-N-(CH2)2-N-Et)(OiPr)2 or

Zr(Et-N-(CH2)2-N-Et)(OiPr)2:將 Et-NH-(CH2)2-NH-Et 之淨 液體緩慢地逐滴添加至在氮氣氛圍下在室溫下授拌的含有 Hf(OiPr)2(NMe2)2 或 Zr(OiPr)2(NMe2)2 之戊烧溶液。將燒瓶 之出口"連接至油起泡器’又將該油起泡器連接至酸洗蘇 器。隔Μ文在室溫下擾拌所得溶液。在真空下將溶劑及揮發 物自反應混合物中移除,從而產生目標分子 (Hf(Et-N-(CH2)2-N-Et)(OiPr)2 或 Zr(Et-N-(CH2)2-N-Et)(〇iPr)2)。 預言性實施例7Zr(Et-N-(CH2)2-N-Et)(OiPr)2: Slowly add a net of Et-NH-(CH2)2-NH-Et to the room temperature under nitrogen atmosphere at room temperature A mixed solution of Hf(OiPr)2(NMe2)2 or Zr(OiPr)2(NMe2)2 was prepared. Connect the flask outlet " to the oil bubbler' and connect the oil bubbler to the pickling dispenser. The resulting solution was scrambled at room temperature. The solvent and volatiles are removed from the reaction mixture under vacuum to produce the target molecule (Hf(Et-N-(CH2)2-N-Et)(OiPr)2 or Zr(Et-N-(CH2)2 -N-Et)(〇iPr)2). Prophetic Example 7

Ti(Me-N-(CH2)2-N-Me)(OiPr)2:將執行類似於實施例 6 之合成,其中反應物具有適當配位基。 預言性實施例8Ti(Me-N-(CH2)2-N-Me)(OiPr)2: A synthesis similar to that of Example 6 will be carried out in which the reactants have a suitable ligand. Prophetic Example 8

Ti(Me2CH-N-(CH2)3-N-CHMe2)(〇iPr)2 :將執行類似於 實施例6之合成,其中反應物具有適當配位基。 預言性實施例9 使用實施例1至8中之任一者的含姶或含锆前驅物及 39 201241224 反應物〇3在SiOVSi基板上沉積Hf02或Zr02膜。將Si02/Si 基板維持在250°C溫度下》使前驅物在維持在5〇。(:下之起泡 器中汽化。ALD循環將包括5秒之前驅物脈衝,繼之以5 秒淨化,繼之以2秒之反應物脈衝,繼之以5秒淨化。預 期Hf〇2或Zr〇2生長速率為0.5 A/循環或大於〇 5 A/循環。 在沉積速率下,分析ALD機制將高達350°C。 預言性實施例1 〇 使用實施例1至8中之任一者的含铪或含鍅前驅物及 反應物KbO在SiOVSi基板上沉積HfCh或Zr02膜。將 SiC^/Si基板維持在250°C溫度下。使前驅物在維持在50°c 下之起泡器中汽化。ALD循環將包括20秒之前驅物脈衝, 繼之以5秒淨化,繼之以2秒之反應物脈衝,繼之以1〇秒 淨化。預期Hf〇2或Zr〇2生長速率為〇·5 A/循環或大於〇.5 A/ 循環。分析ALD機制將高達350°C。 應理解’熟習此項技術者可在如附加申請專利範圍中 所表達的本發明之原理及範疇内,作出本文中已經描述及 說月以便解釋本發明之性質的細節、材料、步驟及份額之 配置的許多額外改變。因此’本發明不意欲限於上文所給 予之貫施例及/或附圖中之特定具體實例。 【圖式簡單說明】 【主要元件符號說明】 無 40Ti(Me2CH-N-(CH2)3-N-CHMe2)(〇iPr)2: A synthesis similar to that of Example 6 will be carried out in which the reactants have a suitable ligand. Prophetic Example 9 An HfO 2 or ZrO 2 film was deposited on a SiOVSi substrate using the cerium- or zirconium-containing precursor of any of Examples 1 to 8 and 39 201241224 reactant 〇3. The SiO 2 /Si substrate was maintained at a temperature of 250 ° C. The precursor was maintained at 5 Torr. (: vaporization in the lower bubbler. The ALD cycle will include the precursor pulse 5 seconds before, followed by a 5 second purge followed by a 2 second reactant pulse followed by a 5 second purge. Expected Hf〇2 or The Zr〇2 growth rate is 0.5 A/cycle or greater than 〇5 A/cycle. At the deposition rate, the analytical ALD mechanism will be as high as 350 ° C. Prophetic Example 1 〇 Using any of Examples 1 to 8 The HfCh or ZrO 2 film is deposited on the SiOVSi substrate with a ruthenium or ruthenium containing precursor and a reactant KbO. The SiC^/Si substrate is maintained at a temperature of 250 ° C. The precursor is maintained in a bubbler maintained at 50 ° C. Vaporization. The ALD cycle will include a precursor pulse of 20 seconds, followed by a 5 second purge followed by a 2 second reactant pulse followed by a 1 second purge. The expected growth rate of Hf〇2 or Zr〇2 is 〇 • 5 A/cycle or greater than 〇5 A/cycle. The analytical ALD mechanism will be as high as 350 ° C. It is to be understood that the skilled person can understand the principles and scope of the invention as expressed in the appended claims. The details, materials, steps, and proportions of the configurations that have been described and described herein to explain the nature of the present invention are made. Multi extra changes. Accordingly 'the present invention is not intended to be limited to the above and to the penetration / Specific embodiments or examples of specific drawings. Brief Description of the drawings [] [] No major components SIGNS LIST 40

Claims (1)

201241224 七、申請專利範圍: 1. 一種具有下式之分子: M(R1-N-C(R3)-N-R2)u(〇R4)x(NR5R6)y(〇2CR7)z 式1 或 其中: Μ為Hf或Zr ; Ri、R2、R5、R6及R7獨立地選自由Η及C1-C6炫基 組成之群; 汉3 = Η、C1-C6 热基,或 NMe2 ; R4為C1-C6烷基; m = 2 至 4 ; u = 0 至 2 ; 'v 二 0 至 1 ; x = 1 至 3 ; y = 0 至 2 ; z = 0 至 1 ; 在式 I 中,u + x+y+ζ = 4 ; 在式 II 中,2v+x+y+z = 4 ;且 u、v 或 z > 1 〇 2. 如申請專利範圍第1項之分子,該分子具有式I ’其 χ~3 , y=〇 ,且 z=〇 〇 3. 如申請專利範圍第2項之分子,其中該分子選自由以 考紐成之群:M(iPr-N-C(Me)-N-iPr)丨(OiPr)3、 201241224 M(iPr-N-C(Me)-N-iPr)1(OMe)3 ' M(iPr-N-C(Me)-N-iPr)!(OEt)3 > M(iPr-N-C(Me)-N-iPr),(OnPr)3 ' M(iPr-N-C(Me)-N-iPr),(OsBu)3 ' M(iPr-N-C(Me)-N-iPr)i(OiBu)3 ' M(iPr-N-C(Me)-N-iPr)!(OtBu)3 ' M(Et-N-C(Me)-N-Et)i(OEt)3 、M(Et-N-C(Me)-N-Et),(OMe)3 、 M(Et-N-C(Me)-N-Et),(OnPr)3 ' M(Et-N-C(Me)-N-Et),(OsBu)3 ' MCEt-N-C^MeVN-EOKOiBu):»、MiEt-N-C^MeyN-EtMOtBuh,及 M(iPr-N-C(NMe2)-N-iPr)(OiPr)3。 4_如申請專利範圍第1項之分子,該分子具有式II,其 中 v=l , x=2 , y=0 ,且 z=0 ° 5 ·如申請專利範圍第4項之分子,其中該分子選自由以 下各者組成之群:M(iPr-N-(CH2)2-N-iPr)丨(OiPr)2、 M(iPr-N-(CH2)2-N-iPr)1(OMe)2 ' M(iPr-N-(CH2)2-N-iPr),(OEt)2 ' M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)2-N-iPr)i(OsBu)2 ' M(iPr-N-(CH2)2-N-iPr)1(OiBu)2 ' M(iPr-N-(CH2)2-N-iPr),(OtBu)2 ' M(Et-N-(CH2)2-N-Et)i(OiPr)2、M(Et-N-(CH2)2-N-Et),(OMe)2、 M(Et-N-(CH2)2-N-Et)1(OEt)2、M(Et-N-(CH2)2-N-Et),(OnPr)2、 M(Et-N-(CH2)2-N-Et)i(OsBu)2 ' M(Et-N-(CH2)2-N-Et),(OiBu)2 ' M(Et-N-(CH2)2-N-Et),(OtBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr),(OMe)2 ' M(iPr-N-(CH2)3-N-iPr)i(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)i(OnPr)2 ' M(iPr-N-(CH2)3-N-iPr)i(OsBu)2 ' M(iPr-N-(CH2)3-N-iPr),(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OtBu)2 ' M(Et-N-(CH2)3-N-Et)1(OiPr)2、M(Et-N-(CH2)3-N-Et)i(OMe)2、 M(Et-N-(CH2)3-N-Et)i(OEt)2 、 M(Et-N-(CH2)3-N-Et)i(OnPr)2 、 IVUEt-lSKCHA-N-EtMOsBuh、MCEt-NJCH^-N-EtMOiBuh,及 42 201241224 MCEt-N-CCHA-N-EthCOtBuh。 6. 如申請專利範圍第1項之分子,該分子具有式I,其 中 u=2 , x=2 , y=0 ,且 z=0 。 7. 如申請專利範圍第6項之分子,其中該分子選自由以 下各者組成之群:M(iPr-N-C(H)-N-iPr)2(OiPr)2 、 M(iPr-N-C(H)-N-iPr)2(OMe)2 、M(iPr-N-C(H)-N-iPr)2(OEt)2 、 M(iPr-N-C(H)-N-iPr)2(OnPr)2、M(iPr-N-C(H)-N-iPr)2(OsBu)2、 M(iPr-N-C(H)-N-iPr)2(OiBu)2、M(iPr-N-C(H)-N-iPr)2(OtBu)2、 M(Et-N-C(H)-N-Et)2(OiPr)2 、 M(Et-N-C(H)-N-Et)2(〇Me)2 、 M(Et-N-C(H)-N-Et)2(OEt)2 、 M(Et-N-C(H)-N-Et)2(〇nPr)2 、 M(Et-N-C(H)-N-Et)2(OsBu)2 、M(Et-N-C(H)-N-Et)2(〇iBu)2 、 M(Et-N-C(H)-N-Et)2(〇tBu)2、M(iPr-N-C(Me)-N-iPr)2(OiPr)2、 M(iPr-N-C(Me)-N-iPr)2(OMe)2、M(iPr-N-C(Me)-N-iPr)2(OEt)2、 M(iPr-N-C(Me)-N-iPr)2(0nPr)2、M(iPr-N-C(Me)-N-iPr)2(OsBu)2、 M(iPr-N-C(Me)-N-iPr)2(OiBu)2、M(iPr-N-C(Me)-N-iPr)2(OtBu)2、 M(Et-N-C(Me)-N-Et)2(OiPr)2 、 M(Et-N-C(Me)-N-Et)2(〇Me)2 、 M(Et-N-C(Me)-N-Et)2(OEt)2、M(Et-N-C(Me)-N-Et)2(OnPr)2 、 M(Et-N-C(Me)-N-Et)2(OsBu)2、M(Et-N-C(Me)-N-Et)2(OiBu)2,及 M(Et-N-C(Me)-N-Et)2(OtBu)2。 8. 如申請專利範圍第1項之分子,該分子具有式I,其 中 u=l, x=2 , y=l ,且 z=0 。 9. 如申請專利範圍第8項之分子,其中該分子選自由以 下各者組成之群:M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2)、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2) 、 43 201241224 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NMe2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEt2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMeiPr) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NiPr2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMetBu) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NneoPentyl2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NMeiPr) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NiPr2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NneoPentyl2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NiPr2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) 及 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMeiPr)。 10.如申請專利範圍第1項之分子,該分子具有式I,其 中 U—1 ’ χ=2 , y=〇 ,且 z=l 。 11 ·如申請專利範圍第10項之分子,其中該分子選自由 以下各者組成之群:M(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) 及 M(Et-N-C(Me)-N-Et)(0iPr)2(02CMe)。 12.如申請專利範圍第1項之分子,該分子具有式π, 201241224 其中 V=1 , χ=1 , y=〇 ,且 z=l 。 13. 如申請專利範圍第12項之分子,其中該分子選自由 以下各者組成之群:M(iPr_N_(CH2)2-N-iPr)(0iPr)(02CMe)、 M(iPr-N-(CH2)2-N-iPr)(OMe)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe) 、 M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0Me)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0Et)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0sBu)(02CMe) 、 M(Et-N-(CH2)2-N-Et)(0iBu)(02CMe) , 及 M(Et-N-(CH2)2-N-Et)(0tBu)(02CMe)。 14. 如申請專利範圍第i項之分子,該分子具有式I或 式 II’ 其中 u、v、y=〇,χ = 2,且 ζ=2。 15_如申請專利範圍第14項之分子,該分子為 M(OiPr)2(〇2CMe)2 〇 1 6.如申請專利範圍第1項之分子,該分子具有式I或 式 II’ 其中 u、v、y=〇,χ=3,且 ζ=1。 17_如_請專利範圍第16項之分子,該分子為 M(OiPr)3(〇2CMe)。 45 201241224 18·一種在基板上形成含Hf或含Zr層之方法,該方法 包含: 提供反應腔室,該反應腔室中安置有至少一基板; 將包括具有以下式之至少一前驅物之蒸汽引入至該 反應腔室中: M(R1-N-C(R3)-N-R2)u(〇R4)x(NR5R6)y(〇2CR7)2 式 I 或 其中: Μ為Hf或Zr ; Ri、R2、R5、R6及R7獨立地選自由Η及CM-C6烷基 紐成之群; R3 = Η、C1-C6 烧基’或 NMe2 ; R4為C1-C6烷基; m = 2 至 4 ; u = 〇 至 2 ; v = 〇 至 1 ; X = 1 至 3 ; y = 0 至 2 ; z = 0 至 1 ; 在式 I 中,u + x+y+z = 4 ; 在式 II 中,2v+x+y+z = 4 ;且 u、v 或 z 2 1 ; 使該蒸汽與該基板接觸以使用氣相沉積製程在該基 46 201241224 板之至少一表面上形成該含Hf或含Zr層。 19.如申請專利範圍第18 物選自由以下各者組成之群 M(iPr-N-C(Me)-N-iPr)!(OMe)3、 M(iPr-N-C(Me)-N-iPr)1(OnPr)3 ' M(iPr-N-C(Me)-N-iPr)1(OiBu)3 ' M(Et-N-C(Me)-N-Et)i(OEt)3 、 M(Et-N-C(Me)-N-Et)i(OnPr)3 、 M(Et-N-C(Me)-N-Et)i(OiBu)3 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)3、 M(iPr-N-(CH2)2-N-iPr)1(OMe)2 ' M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)2-N-iPr)i(OiBu)2 ' M(Et-N-(CH2)2-N-Et)1(OiPr)2 、 M(Et-N-(CH2)2-N-Et)i(OEt)2 、 M(Et-N-(CH2)2-N-Et)1(OsBu)2 、 M(Et-N-(CH2)2-N-Et)1(OtBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OMe)2 > M(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)3-N-iPr)1(OiBu)2 ' M(Et-N-(CH2)3-N-Et)i(OiPr)2 、 M(Et-N-(CH2)3-N-Et)1(OEt)2 、 M(Et-N-(CH2)3-N-Et)1(OsBu)2 、 M(Et-N-(CH2)3-N-Et)i(OtBu)2 、 項之方法,其中該至少一前驅 M(iPr-N-C(Me)-N-iPr)!(OiPr)3 ' M(iPr-N-C(Me)-N-iPr),(OEt)3、 M(iPr-N-C(Me)-N-iPr)!(OsBu)3 ' M(iPr-N-C(Me)-N-iPr)!(OtBu)3 ' M(Et-N-C(Me)-N-Et)!(OMe)3 、 M(Et-N-C(Me)-N-Et),(OsBu)3 、 M(Et-N-C(Me)-N-Et)i(OtBu)3 、 M(iPr-N-(CH2)2-N-iPr),(OiPr)2 ' M(iPr-N-(CH2)2-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)2-N-iPr)1(OsBu)2 ' M(iPr-N-(CH2)2-N-iPr)1(OtBu)2 ' M(Et-N-(CH2)2-N-Et)1(OMe)2 、 M(Et-N-(CH2)2-N-Et)i(OnPr)2 、 M(Et-N-(CH2)2-N-Et)](OiBu)2 、 M(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)1(OsBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OtBu)2 ' M(Et-N-(CH2)3-N-Et)i(OMe)2 、 M(Et-N-(CH2)3-N-Et)1(OnPr)2 、 M(Et-N-(CH2)3-N-Et)i(OiBu)2 、 M(iPr-N-C(H)-N-iPr)2(OiPr)2 、 47 201241224 M(iPr-N-C(H)-N-iPr)2(OMe)2 、M(iPr-N-C(H)-N-iPr)2(OEt)2 、 M(iPr-N-C(H)-N-iPr)2(OnPr)2、M(iPr-N-C(H)-N-iPr)2(OsBu)2、 M(iPr-N-C(H)-N-iPr)2(OiBu)2、M(iPr-N-C(H)-N-iPr)2(OtBu)2、 M(Et-N-C(H)-N-Et)2(OiPr)2 、 M(Et-N-C(H)-N-Et)2(OMe)2 、 M(Et-N-C(H)-N-Et)2(OEt)2 、 M(Et-N-C(H)-N-Et)2(OnPr)2 、 M(Et-N-C(H)-N-Et)2(OsBu)2 、 M(Et-N-C(H)-N-Et)2(OiBu)2 、 M(Et-N-C(H)-N-Et)2(OtBu)2 、 M(iPr-N-C(Me)-N-iPr)2(OiPr)2 、 M(iPr-N-C(Me)-N-iPr)2(OMe)2、M(iPr-N-C(Me)-N-iPr)2(OEt)2、 M(iPr-N-C(Me)-N-iPr)2(OnPr)2、M(iPr-N-C(Me)-N-iPr)2(OsBu)2、 M(iPr-N-C(Me)-N-iPr)2(OiBu)2、M(iPr-N-C(Me)-N-iPr)2(OtBu)2、 M(Et-N-C(Me)-N-Et)2(OiPr)2 、 M(Et-N-C(Me)-N-Et)2(OMe)2 、 M(Et-N-C(Me)-N-Et)2(OEt)2 、M(Et-N-C(Me)-N-Et)2(〇nPr)2 、 M(Et-N-C(Me)-N-Et)2(OsBu)2 、.M(Et-N-C(Me)-N-Et)2(OiBu)2 、 M(Et-N-C(Me)-N-Et)2(OtBu)2 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NMe2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEt2) 、 M(iPr-N-C(Me)-N-iPr)(OiPr)2(NEtMe) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NMe2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEt2) 、 M(Et-N-C(Me)-N-Et)(OiPr)2(NEtMe) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NMe2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEt2) 、 M(iPr-N-C(NMe2)-N-iPr)(OiPr)2(NEtMe) 、 M(iPr-N-C(Me)-N-iPr)(0iPr)2(02CMe) 、 48 201241224 M(Et-N-C(Me)-N-Et)(0iPr)2(02CMe) M(iPr-N-(CH2)2-N-iPr)(0iPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Me)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0nPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(OsBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) M(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0Me)(02CMe) M(Et-N-(CH2)2-N-Et)(0Et)(02CMe) M(Et-N-(CH2)2-N-Et)(0nPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0sBu)(02CMe) M(Et-N-(CH2)2-N-Et)(0iBu)(02CMe) M(0iPr)2(02CMe)2 ,及 M(Et-N-(CH2)2-N-Et)(0tBu)(02CMe)、 M(0iPr)3(02CMe)。 八、圖式: (無) 49201241224 VII. Patent application scope: 1. A molecule having the following formula: M(R1-NC(R3)-N-R2)u(〇R4)x(NR5R6)y(〇2CR7)z Formula 1 or wherein: Μ Rf or Zr; Ri, R2, R5, R6 and R7 are independently selected from the group consisting of ruthenium and C1-C6 ray; Han 3 = Η, C1-C6 thermal group, or NMe2; R4 is C1-C6 alkyl m = 2 to 4; u = 0 to 2; 'v 2 0 to 1; x = 1 to 3; y = 0 to 2; z = 0 to 1; in Equation I, u + x+y+ζ = 4 ; In Formula II, 2v+x+y+z = 4; and u, v or z > 1 〇2. As claimed in the first item of the patent scope, the molecule has the formula I 'χχ3 , y=〇, and z=〇〇3. The molecule of claim 2, wherein the molecule is selected from the group consisting of: K(iPr-NC(Me)-N-iPr)丨(OiPr) 3, 201241224 M(iPr-NC(Me)-N-iPr)1(OMe)3 ' M(iPr-NC(Me)-N-iPr)!(OEt)3 > M(iPr-NC(Me )-N-iPr), (OnPr)3 ' M(iPr-NC(Me)-N-iPr), (OsBu)3 ' M(iPr-NC(Me)-N-iPr)i(OiBu)3 ' M(iPr-NC(Me)-N-iPr)!(OtBu)3 ' M(Et-NC(Me)-N-Et)i(OEt)3 , M(Et-NC(Me)-N-Et ), (OMe)3, M(Et-NC(Me)-N-Et), (OnPr)3 'M(Et-NC(Me) -N-Et), (OsBu)3 'MCEt-N-C^MeVN-EOKOiBu):», MiEt-N-C^MeyN-EtMOtBuh, and M(iPr-N-C(NMe2)-N-iPr)(OiPr)3. 4_, as in the numerator of claim 1, the molecule has the formula II, wherein v = l, x = 2, y = 0, and z = 0 ° 5 · The molecule of claim 4, wherein The molecule is selected from the group consisting of M(iPr-N-(CH2)2-N-iPr)丨(OiPr)2, M(iPr-N-(CH2)2-N-iPr)1(OMe) 2 ' M(iPr-N-(CH2)2-N-iPr),(OEt)2 ' M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' M(iPr-N- (CH2)2-N-iPr)i(OsBu)2 ' M(iPr-N-(CH2)2-N-iPr)1(OiBu)2 ' M(iPr-N-(CH2)2-N-iPr ),(OtBu)2 ' M(Et-N-(CH2)2-N-Et)i(OiPr)2, M(Et-N-(CH2)2-N-Et), (OMe)2, M (Et-N-(CH2)2-N-Et)1(OEt)2, M(Et-N-(CH2)2-N-Et), (OnPr)2, M(Et-N-(CH2) 2-N-Et)i(OsBu)2 ' M(Et-N-(CH2)2-N-Et), (OiBu)2 ' M(Et-N-(CH2)2-N-Et),( OtBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr), (OMe)2 ' M(iPr- N-(CH2)3-N-iPr)i(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)i(OnPr)2 ' M(iPr-N-(CH2)3-N -iPr)i(OsBu)2 ' M(iPr-N-(CH2)3-N-iPr),(OiBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OtBu)2 'M(Et-N-(CH2)3-N-Et)1(OiPr)2, M(Et-N-(CH2)3-N-Et)i(OMe)2, M(Et-N-( CH2)3-N-Et)i(OEt)2, M(Et-N-(CH2)3-N-Et)i(OnPr)2, IVUEt-lSKCHA- N-EtMOsBuh, MCEt-NJCH^-N-EtMOiBuh, and 42 201241224 MCEt-N-CCHA-N-EthCOtBuh. 6. For the numerator of claim 1 of the patent, the molecule has the formula I, where u=2, x=2, y=0, and z=0. 7. A molecule according to claim 6 wherein the molecule is selected from the group consisting of M(iPr-NC(H)-N-iPr)2(OiPr)2, M(iPr-NC(H) )-N-iPr)2(OMe)2, M(iPr-NC(H)-N-iPr)2(OEt)2, M(iPr-NC(H)-N-iPr)2(OnPr)2 M(iPr-NC(H)-N-iPr)2(OsBu)2, M(iPr-NC(H)-N-iPr)2(OiBu)2, M(iPr-NC(H)-N-iPr 2(OtBu)2, M(Et-NC(H)-N-Et)2(OiPr)2, M(Et-NC(H)-N-Et)2(〇Me)2, M(Et- NC(H)-N-Et)2(OEt)2, M(Et-NC(H)-N-Et)2(〇nPr)2, M(Et-NC(H)-N-Et)2( OsBu)2, M(Et-NC(H)-N-Et)2(〇iBu)2, M(Et-NC(H)-N-Et)2(〇tBu)2, M(iPr-NC( Me)-N-iPr)2(OiPr)2, M(iPr-NC(Me)-N-iPr)2(OMe)2, M(iPr-NC(Me)-N-iPr)2(OEt)2 , M(iPr-NC(Me)-N-iPr)2(0nPr)2, M(iPr-NC(Me)-N-iPr)2(OsBu)2, M(iPr-NC(Me)-N- iPr)2(OiBu)2, M(iPr-NC(Me)-N-iPr)2(OtBu)2, M(Et-NC(Me)-N-Et)2(OiPr)2, M(Et- NC(Me)-N-Et)2(〇Me)2, M(Et-NC(Me)-N-Et)2(OEt)2, M(Et-NC(Me)-N-Et)2( OnPr)2, M(Et-NC(Me)-N-Et)2(OsBu)2, M(Et-NC(Me)-N-Et)2(OiBu)2, and M(Et-NC(Me )-N-Et) 2 (OtBu) 2. 8. As claimed in the first paragraph of the patent scope, the molecule has the formula I, wherein u = l, x = 2, y = l, and z = 0. 9. A molecule according to claim 8 wherein the molecule is selected from the group consisting of M(iPr-NC(Me)-N-iPr)(OiPr)2(NMe2), M(iPr-NC (Me)-N-iPr)(OiPr)2(NEt2), 43 201241224 M(iPr-NC(Me)-N-iPr)(OiPr)2(NEtMe) , M(Et-NC(Me)-N- Et)(OiPr)2(NMe2), M(Et-NC(Me)-N-Et)(OiPr)2(NEt2), M(Et-NC(Me)-N-Et)(OiPr)2(NEtMe ), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMe2), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NEt2), M(iPr-NC( NMe2)-N-iPr)(OiPr)2(NEtMe), M(iPr-NC(Me)-N-iPr)(OiPr)2(NMeiPr), M(iPr-NC(Me)-N-iPr)( OiPr)2(NiPr2), M(iPr-NC(Me)-N-iPr)(OiPr)2(NMetBu), M(iPr-NC(Me)-N-iPr)(OiPr)2(NneoPentyl2), M (Et-NC(Me)-N-Et)(OiPr)2(NMeiPr), M(Et-NC(Me)-N-Et)(OiPr)2(NiPr2), M(Et-NC(Me)- N-Et)(OiPr)2(NneoPentyl2), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMeiPr), M(iPr-NC(NMe2)-N-iPr)(OiPr)2 (NiPr2), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NneoPentyl2) and M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMeiPr). 10. The molecule of claim 1, wherein the molecule has the formula I, wherein U-1' χ = 2, y = 〇, and z = l. 11. A molecule according to claim 10, wherein the molecule is selected from the group consisting of M(iPr-NC(Me)-N-iPr)(0iPr)2(02CMe) and M(Et-NC) (Me)-N-Et) (0iPr) 2 (02CMe). 12. The molecule of claim 1, wherein the molecule has the formula π, 201241224 wherein V=1, χ=1, y=〇, and z=l. 13. The molecule of claim 12, wherein the molecule is selected from the group consisting of M(iPr_N_(CH2)2-N-iPr)(0iPr)(02CMe), M(iPr-N-( CH2)2-N-iPr)(OMe)(02CMe) , M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) , M(iPr-N-(CH2)2-N- iPr)(0nPr)(02CMe) , M(iPr-N-(CH2)2-N-iPr)(0sBu)(02CMe) , M(iPr-N-(CH2)2-N-iPr)(0iBu)( 02CMe) , M(iPr-N-(CH2)2-N-iPr)(0tBu)(02CMe) , M(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) , M(Et -N-(CH2)2-N-Et)(0Me)(02CMe), M(Et-N-(CH2)2-N-Et)(0Et)(02CMe), M(Et-N-(CH2) 2-N-Et)(0nPr)(02CMe) , M(Et-N-(CH2)2-N-Et)(0sBu)(02CMe) , M(Et-N-(CH2)2-N-Et) (0iBu)(02CMe), and M(Et-N-(CH2)2-N-Et)(0tBu)(02CMe). 14. The molecule of claim i, wherein the molecule has the formula I or formula II' wherein u, v, y = 〇, χ = 2, and ζ = 2. 15_ If the molecule of claim 14 is a molecule, the molecule is M(OiPr)2(〇2CMe)2 〇1 6. As the molecule of claim 1, the molecule has formula I or formula II' where u , v, y=〇, χ=3, and ζ=1. 17_如_ The molecule of the 16th patent range, the molecule is M(OiPr)3(〇2CMe). 45 201241224 18· A method of forming a Hf-containing or Zr-containing layer on a substrate, the method comprising: providing a reaction chamber in which at least one substrate is disposed; steam comprising at least one precursor having the following formula Introduced into the reaction chamber: M(R1-NC(R3)-N-R2)u(〇R4)x(NR5R6)y(〇2CR7)2 Formula I or wherein: Μ is Hf or Zr; Ri, R2 , R5, R6 and R7 are independently selected from the group consisting of hydrazine and CM-C6 alkyl; R3 = hydrazine, C1-C6 alkyl group or NMe2; R4 is C1-C6 alkyl; m = 2 to 4; = 〇 to 2 ; v = 〇 to 1 ; X = 1 to 3 ; y = 0 to 2 ; z = 0 to 1 ; in Equation I, u + x + y + z = 4 ; In Equation II, 2v +x+y+z = 4; and u, v or z 2 1 ; contacting the vapor with the substrate to form the Hf-containing or Zr-containing layer on at least one surface of the substrate 46 201241224 using a vapor deposition process . 19. The object of claim 18 is selected from the group consisting of M(iPr-NC(Me)-N-iPr)! (OMe)3, M(iPr-NC(Me)-N-iPr)1 (OnPr)3 ' M(iPr-NC(Me)-N-iPr)1(OiBu)3 ' M(Et-NC(Me)-N-Et)i(OEt)3 , M(Et-NC(Me )-N-Et)i(OnPr)3, M(Et-NC(Me)-N-Et)i(OiBu)3, M(iPr-NC(NMe2)-N-iPr)(OiPr)3, M (iPr-N-(CH2)2-N-iPr)1(OMe)2 ' M(iPr-N-(CH2)2-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2) 2-N-iPr)i(OiBu)2 ' M(Et-N-(CH2)2-N-Et)1(OiPr)2 , M(Et-N-(CH2)2-N-Et)i( OEt)2, M(Et-N-(CH2)2-N-Et)1(OsBu)2, M(Et-N-(CH2)2-N-Et)1(OtBu)2 'M(iPr- N-(CH2)3-N-iPr)1(OMe)2 > M(iPr-N-(CH2)3-N-iPr)1(OnPr)2 ' M(iPr-N-(CH2)3- N-iPr)1(OiBu)2 ' M(Et-N-(CH2)3-N-Et)i(OiPr)2 , M(Et-N-(CH2)3-N-Et)1(OEt) 2, M(Et-N-(CH2)3-N-Et)1(OsBu)2, M(Et-N-(CH2)3-N-Et)i(OtBu)2, the method of the item, wherein At least one precursor M (iPr-NC(Me)-N-iPr)!(OiPr)3 'M(iPr-NC(Me)-N-iPr), (OEt)3, M(iPr-NC(Me)- N-iPr)!(OsBu)3 ' M(iPr-NC(Me)-N-iPr)!(OtBu)3 ' M(Et-NC(Me)-N-Et)!(OMe)3 , M( Et-NC(Me)-N-Et), (OsBu)3, M(Et-NC(Me)-N-Et)i(OtBu)3, M(iPr-N-(CH2) 2-N-iPr),(OiPr)2 ' M(iPr-N-(CH2)2-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)2-N-iPr)1( OsBu)2 ' M(iPr-N-(CH2)2-N-iPr)1(OtBu)2 ' M(Et-N-(CH2)2-N-Et)1(OMe)2 , M(Et- N-(CH2)2-N-Et)i(OnPr)2, M(Et-N-(CH2)2-N-Et)](OiBu)2, M(iPr-N-(CH2)3-N -iPr)1(OiPr)2 ' M(iPr-N-(CH2)3-N-iPr)1(OEt)2 ' M(iPr-N-(CH2)3-N-iPr)1(OsBu)2 ' M(iPr-N-(CH2)3-N-iPr)1(OtBu)2 ' M(Et-N-(CH2)3-N-Et)i(OMe)2 , M(Et-N-( CH2)3-N-Et)1(OnPr)2, M(Et-N-(CH2)3-N-Et)i(OiBu)2, M(iPr-NC(H)-N-iPr)2( OiPr)2, 47 201241224 M(iPr-NC(H)-N-iPr)2(OMe)2, M(iPr-NC(H)-N-iPr)2(OEt)2, M(iPr-NC( H)-N-iPr)2(OnPr)2, M(iPr-NC(H)-N-iPr)2(OsBu)2, M(iPr-NC(H)-N-iPr)2(OiBu)2 , M(iPr-NC(H)-N-iPr)2(OtBu)2, M(Et-NC(H)-N-Et)2(OiPr)2, M(Et-NC(H)-N- Et)2(OMe)2, M(Et-NC(H)-N-Et)2(OEt)2, M(Et-NC(H)-N-Et)2(OnPr)2, M(Et- NC(H)-N-Et)2(OsBu)2, M(Et-NC(H)-N-Et)2(OiBu)2, M(Et-NC(H)-N-Et)2(OtBu 2, M(iPr-NC(Me)-N-iPr)2(OiPr)2, M(iPr-NC(Me)-N-iPr)2(OMe)2, M(iPr-NC(Me)- N-iPr)2(OEt)2, M(iPr-NC(Me)-N-iPr)2(OnPr)2, M(iPr -NC(Me)-N-iPr)2(OsBu)2, M(iPr-NC(Me)-N-iPr)2(OiBu)2, M(iPr-NC(Me)-N-iPr)2( OtBu)2, M(Et-NC(Me)-N-Et)2(OiPr)2, M(Et-NC(Me)-N-Et)2(OMe)2, M(Et-NC(Me) -N-Et)2(OEt)2, M(Et-NC(Me)-N-Et)2(〇nPr)2, M(Et-NC(Me)-N-Et)2(OsBu)2, .M(Et-NC(Me)-N-Et)2(OiBu)2 , M(Et-NC(Me)-N-Et)2(OtBu)2 , M(iPr-NC(Me)-N- iPr)(OiPr)2(NMe2), M(iPr-NC(Me)-N-iPr)(OiPr)2(NEt2), M(iPr-NC(Me)-N-iPr)(OiPr)2(NEtMe ), M(Et-NC(Me)-N-Et)(OiPr)2(NMe2), M(Et-NC(Me)-N-Et)(OiPr)2(NEt2), M(Et-NC( Me)-N-Et)(OiPr)2(NEtMe), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NMe2), M(iPr-NC(NMe2)-N-iPr)( OiPr)2(NEt2), M(iPr-NC(NMe2)-N-iPr)(OiPr)2(NEtMe), M(iPr-NC(Me)-N-iPr)(0iPr)2(02CMe), 48 201241224 M(Et-NC(Me)-N-Et)(0iPr)2(02CMe) M(iPr-N-(CH2)2-N-iPr)(0iPr)(02CMe) M(iPr-N-(CH2 )2-N-iPr)(0Me)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0Et)(02CMe) M(iPr-N-(CH2)2-N-iPr)( 0nPr)(02CMe) M(iPr-N-(CH2)2-N-iPr)(OsBu)(02CMe) M(iPr-N-(CH2)2-N-iPr)(0iBu)(02CMe) M(iPr -N-(CH2)2-N-iPr)(0tBu)(02CMe) M(Et-N-(CH2)2-N-Et)(0iPr)(02CMe) M(Et-N-(CH2)2-N-Et)(0Me)(02CMe) M(Et-N-(CH2) ))(Nt-N-(CH2)2-N-Et)(0nPr)(02CMe) M(Et-N-(CH2)2-N-Et)( 0sBu)(02CMe) M(Et-N-(CH2)2-N-Et)(0iBu)(02CMe) M(0iPr)2(02CMe)2 , and M(Et-N-(CH2)2-N- Et) (0tBu) (02CMe), M (0iPr) 3 (02CMe). Eight, schema: (none) 49
TW100112135A 2011-04-06 2011-04-06 Hafnium-containing or zirconium-containing precursors for vapor deposition TWI518199B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW100112135A TWI518199B (en) 2011-04-06 2011-04-06 Hafnium-containing or zirconium-containing precursors for vapor deposition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW100112135A TWI518199B (en) 2011-04-06 2011-04-06 Hafnium-containing or zirconium-containing precursors for vapor deposition

Publications (2)

Publication Number Publication Date
TW201241224A true TW201241224A (en) 2012-10-16
TWI518199B TWI518199B (en) 2016-01-21

Family

ID=47599994

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100112135A TWI518199B (en) 2011-04-06 2011-04-06 Hafnium-containing or zirconium-containing precursors for vapor deposition

Country Status (1)

Country Link
TW (1) TWI518199B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI838641B (en) * 2020-09-08 2024-04-11 南韓商韓松化學股份有限公司 Group 4 metal element-containing compound, precursor composition containing same, and method for forming thin film using same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI838641B (en) * 2020-09-08 2024-04-11 南韓商韓松化學股份有限公司 Group 4 metal element-containing compound, precursor composition containing same, and method for forming thin film using same

Also Published As

Publication number Publication date
TWI518199B (en) 2016-01-21

Similar Documents

Publication Publication Date Title
KR101304760B1 (en) Titanium-containing precursors for vapor deposition
JP6337116B2 (en) Group 5 transition metal-containing compound for depositing a Group 5 transition metal-containing film
JP2020504779A (en) Lanthanide precursors and deposition of lanthanide-containing films using the same
TWI496929B (en) Hafnium-and zirconium-containing precursors and methods of using the same
US20120308739A1 (en) Methods for deposition of alkaline earth metal fluoride films
TW201116643A (en) Method of forming dielectric films, new precursors and their use in the semi-conductor manufacturing
EP2499274B1 (en) Deposition methods using hafnium-containing compounds
TW201630921A (en) Zirconium-containing film forming compositions for vapor deposition of zirconium-containing films
TW201335417A (en) Silicon containing compounds for ALD deposition of metal silicate films
KR101721294B1 (en) Hafnium-containing or zirconium-containing precursors for vapor deposition
US20170018425A1 (en) Heteroleptic diazadienyl group 4 transition metal-containing compounds for vapor deposition of group 4 transition metal-containing films
TWI756959B (en) Film or coating by an ald process on a substrate
WO2014118751A1 (en) Manganese-containing compounds, their synthesis, and use in manganese-containing film deposition
KR102209476B1 (en) Cobalt-containing compounds, their synthesis, and use in cobalt-containing film deposition
US20160032454A1 (en) Bis(alkylimido)-bis(alkylamido)tungsten molecules for deposition of tungsten-containing films
TWI518199B (en) Hafnium-containing or zirconium-containing precursors for vapor deposition
WO2014118750A1 (en) Manganese-containing compounds, their synthesis, and use in manganese-containing film deposition